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ABSTRACT 
The postsynaptic density (PSD) is an electron dense structure just beneath the 
postsynaptic membrane. Several functions have been proposed for the PSD including 
regulating receptor number and clustering, anchoring signal transduction molecules at the 
synapse and mediating adhesion between the presynaptic and postsynaptic membranes. 
However, little was known about the proteins that make up the PSD until the biochemical 
purification of a PSD fraction from brain was established in 1974. Since then, several 
interesting proteins have been localized to the PSD fraction. The most abundant PSD 
protein is the a subunit of the type I1 calciudcalmodulin dependent protein kinase 
(aCaMKn). This protein is likely to play a role in the calcium-mediated signal 
transduction at the synapse that mediates certain forms of synaptic plasticity. Another 
major PSD protein is PSD-95, a member of the guanylate kinase family (GUK) of 
proteins. 
Here, I describe the purification and identification of three additional PSD proteins 
that comigrate at a molecular weight of 180 kDa on SDS-polyactylamide gels. First, PSD- 
gp180 is identified as the 2B subunit of the N-methyl-D-aspartate receptor (NR2B). 
NR2B is a major component of the PSD fraction and binds to PSD-95 in vitro. This 
interaction may anchor NMDA receptors at the synapse. 
Next, I report the cloning and characterization of densin- 180, a 180 kDa PSD 
protein with a novel adhesion molecule-like sequence. Densin-1 80 is a brain-specific 
sialornucin that is enriched in the PSD fraction and localized to the synapse by 
immunocytochemistty . 
In order to study the assembly of PSD proteins at the synapse, I use antibodies 
against aCaMKII, PSD-95 and densin- 180 for double labeling cultured hippocampal 
neurons. In these cultures, densin-180 protein is the first marker to be expressed and this 
early densin- 180 expression is in a diffuse membrane pattern dong dendrites. When 
synapse formation begins at about 5 days after plating, the densin-1 80 protein is clustered 
at synapses and PSD-95 expression is induced. PSD-95 colocalizes with densin- 180 
clusters. The aCaMKII protein is expressed later in synapse formation (7 to 9 days in 
vitro) and may be a marker of mature excitatory neurons. 
In the brain, densin- 180 is localized to the neuropil regions in a punctate pattern 
likely to represent synaptic staining. In addition, anti-densin- 180 is localized to a specific 
set of cells and that may represent undifferentiated neurons and small processes that may 
represent dendritic filopodia. 
The third 180 kDa PSD protein is citron, a recently identified Rho/Rac binding 
protein. The citron sequence contains numerous motifs found in signal transduction 
proteins and a myosin-like coiled coil domain. Citron may be a target for Rho/Rac- 
dependent signal transduction at the synapse and may mediate physical stabilization of the 
postsynaptic density. 
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In this introduction, I discuss the structure of the CNS synapse, proposed functions 
of the postsynaptic density (PSD), and methods used for the study of PSD proteins. My 
review of molecules involved in long-term potentiation is not extensive and is simply used 
to illustrate some of our motivations in studying PSD proteins. I only briefly mention the 
characterization of densin- 180 because this is described in detail in Chapter 3. In the 
second part of the introduction, I provide a general overview of adhesion mediated by 
molecules that are similar to densin- 180 and suggest that densin- 180 may mediate similar 
mechanisms of adhesion at the synapse. 
Methods for studying neuronal function 
The study of brain function has exploded over the last 50 years with the discovery 
of new cell biological techniques. First, the advent of microscopy allowed scientists to view 
the fine structure of neurons. Electron microscopy in particular revealed many aspects of 
mechanisms by which the brain is put together and has contributed to a number of 
hypotheses about how neurons communicate. Electrophysiology has enabled the study of 
the electrical properties of neurons, absolutely essential to their function. The recent 
advances in molecular biology and biochemistry have enabled us to determine protein 
structures, even at the atomic level. More recently, genetic engineering techniques have 
allowed us to test individual protein functions by generating mouse mutants in these 
proteins and assaying the effects of the mutations. These methods can be particularly 
powerful when used in combination to study the nervous system. 
The first synapse studied in detail was the neuromuscular junction. Electron 
microscopists first identified vesicles in the nerve terminals at synapses on muscle fibers. 
They speculated that these vesicles might contain neurotransmitter that was released by the 
nerve to activate muscle contraction. Physiologists confirmed this hypothesis by proving 
that the neurotransmitter (acetylcholine) was released in quanta to induce a depolarizing 
current in the muscle fiber (Fatt and Katz, 1954). Other electrophysiologists were able to 
show that the postsynaptic response was mediated by ion flow through a neurotransmitter 
receptor. Similar methods were also used to identify an acetylcholine receptor (AChR) at 
the synapse and to show that this receptor is sensitive to a-bungasotoxin, a toxin that 
causes muscle paralysis. The AChR was purified based on tight binding to alpha 
bungarotoxin and the primary structure was determined by biochemical and molecular 
genetic methods. More recently, a large number of molecules of the pre and postsynaptic 
specializations have been discovered and are thought to be involved in the formation and 
functioning of the neuromuscular junction (Reviewed in Fallon and Hall, 1994 and 
Froehner and Fallon, 1995). 
Molecular mechanisms and synaptic plasticity 
The research of synaptic transmission in the central nervous system has recently 
become focused on the study of synaptic plasticity, in particular the form of synaptic 
plasticity called long-term potentiation (LTP). LTP is a mechanism by which an excitatory 
response of a neuron can be strengthened by prior high frequency stimulation to increase 
subsequent responses to low frequency stimulations. It is thought that neurons use this 
memory of prior stimulation to encode memory formation by the hippocampus. Despite 
the large number of labs studying LTP, there is no "unified hypothesis" about how it 
works. Rather, there has been much recent controversy over whether maintenance of LTP 
is a presynaptic or postsynaptic phenomenon (reviewed in Madison and Schuman, 199 1 
and Edwards, 199 1). 
Despite the controversy, there are two very nice examples of proteins that have 
been proven to play an important role in the generation of LTP. The NMDA-type 
glutmate receptor (NMDAR) has been shown to be essential for LTP by several criteria 
(see Collingridge, 1995 for review). First, the induction of LTP can be blocked by treating 
neurons with APV, a specific inhibitor of NMDARs (Morris et al., 1986). 
Electrophysiological experiments revealed an interesting aspect of NMDAR regulation that 
is likely to mediate it's role in LTP. At or near resting membrane potentials, NMDARs are 
inactive because magnesium blocks the pore of the channel, but at elevated membrane 
potentials, the magnesium block is weakened and the channels can open in response to 
ligand binding. Molecular cloning of the NMDAR subunits, followed by study of the 
receptor expressed in heterologous cells, confirmed their ability to conduct calcium in a 
voltage-dependent manner similar to the native receptor. Lastly, in the brain, certain 
memory enhancing drugs act by directly binding to NMDARs. 
The second protein implicated in the formation of LTP is the type I1 
Ca2+-calmodulin dependent protein kinase (CaMKII). This kinase has been implicated in 
the generation of LTP in response to calcium entry through the NMDARs by a number of 
different approaches. First, elegant biochemical studies of the regulation of CaMKII 
identified a molecular mechanism that might underlie memory formation. CaMKII is 
normally dependent on cdcium/calmodulin for activity. However, the autophospholylated 
form of CaMKII has a high level of calcium-independent activity. Thus, CaMKII has the 
potential to become autophospholylated upon calcium entry at the synapse and to stay 
active even after the calcium concentration returns to resting levels (Kennedy et al., 1990). 
This finding motivated several labs to investigate the role of CaMKII further. Malinow et 
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al., 1989 showed that addition of specific pseudosubstrates that inhibit CaMKII also block 
LTP. As additional evidence, transgenic mice were generated that lack the alpha subunit of 
CaMKII. These mice do not exhibit LTP and have some memory defects (for review, see 
Stevens et al., 1994). 
In an elegant set of experiments, nitric oxide (NO) was implicated as a retrograde 
messenger important in the formation and maintenance of LTP at synapses in area CA1 of 
the hippocampus (for review, see Schuman and Madison, 1994). The cloning of three 
forms of nitric oxide synthase (NOS) that are activated by ca2+/calmodulin suggested that 
a form of NOS might be located in the postsynaptic compartment and produce NO in 
response to calcium influx through glutamate receptors. However, the isoform of NOS 
first termed the "neuronal" NOS (nNOS) did not appear to be localized at synapses in area 
CA1 of the hippocampus by immunocytochemistry. Additionally, a mouse knockout 
mutant missing the neuronal NOS did not show a defect in LTP (Huang et al., 1993). 
More recently, the isoform of NOS first termed the "endothelial" NOS (eNOS) has been 
found to be expressed in high concentration in CAI pyramidal neurons. However, the 
only defect reported in the mouse knockout mutant missing the "endothelial" form of 
NOS is high blood pressure (Huang et al., 1995). One possibility is that eNOS and nNOS 
have somewhat redundant functions in CAI neurons. Another possibility is that the 
expression of one form of NOS is induced to compensate for the loss of the other isofom. 
Double mouse mutants that lack both forms of NOS may clarify these issues. 
The above examples illustrate the power of structural studies of the synapse that 
complement pharmacological and physiological studies. My research has been motivated 
in part by the need to identify the full complement of proteins located at the synapse in 
order to more fully understand the mechanisms that underlie synaptic plasticity. 
Structure of the CNS synapse 
Examination of the brain by electron microscopy resulted in the identification of a 
synaptic structure that is reminiscent of the synapse at the neuromuscular junction. A 
compact presynaptic terminal contains small, clear vesicles that have been shown to contain 
neurotransmitters. Neurotransmitter receptors are believed to be clustered in the 
postsynaptic membrane apposed to the presynaptic terminal and separated from the 
presynaptic membrane by a uniform synaptic cleft containing electron dense material. 
However, unlike the neuromuscular junction, the synapse in the central nervous system 
(CNS) has a unique postsynaptic specialization known as a spine. This synapse is 
characterized by a spiny postsynaptic protrusion from the dendritic shaft that meets the 
axon terminal. The spine has the potential to compartmentalize proteins and molecules 
necessary for synaptic transmission and/or regulation of the synapse structure (see Harris 
and Kater, 1994). Recent evidence suggests that differences in spine morphology may 
underlie the ability of neurons to exhibit LTP (Harris et al., 1992). 
Excitatory synapses in the CNS are characterized by a particularly large, dense 
thickening just beneath the postsynaptic membrane, termed the postsynaptic density. 
Figure 1.1 shows an electron micrograph of serial thin sections through a single synapse in 
the hippocampus. This figure highlights the tight correlation between the presence of 
docked vesicles at the presynaptic membrane and the thick PSD underneath the 
postsynaptic membrane, suggesting a high degree of coordination between protein 
assemblies at the pre and postsynaptic membranes (Harris and Sultan, 1995). Based 
entirely on pictures like these, early electron microscopists proposed several functions for 
the PSD, including regulation of adhesion between the presynaptic and postsynaptic 
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membranes, anchoring of neurotransmitter receptors at the postsynaptic membrane, and 
maintenance of the structure of the synapse. 
Proteins of the PSI) fraction 
In 1974, Cotman et a1. first developed a procedure for purifying a subcellular 
fraction termed the PSD fraction. Cohen et al. (1977) modified the original preparation by 
developing a protocol that used milder detergent extraction and resulted in higher recovery 
of PSD protein. Essentially, the PSD fraction is purified by centrifugation after detergent 
extraction of synaptosomes prepared from brain homogenates. During homogenization of 
brain tissue, the PSD remains attached to synaptosomes probably via adhesion molecules 
that cross the synaptic junction. The detergent Triton-XI00 (0.5%) dissolves 
synaptosomal membranes and a subsequent pelleting of the insoluble fraction gives 
purified PSDs, relatively free of presynaptic membranes. The structures that are enriched 
by this purification have a morphology similar to that of intact brain PSDs viewed in the 
electron microscope (Figure 1.2). The remarkable similarity between the structures of the 
brain PSD and the PSD fraction suggests that this fraction is made up of the same set of 
protein components as the PSD in the brain. This biochemical purification has enabled our 
lab and others to identify individual proteins in the PSD. 
The first labs to work with the PSI) fraction used antibodies to characterize a 
number of major proteins such as fodrin, actin and tubulin. More recently, labs have used 
antibodies against known proteins to identify the AMPA-type glutamate receptor, GluR1, 
and an "A-kinase anchoring protein" as (albeit minor) components of the PSD fraction 
(Rogers et al., 1991 and Carr et al., 1992). There are many other proteins reported in the 
literature that are associated with the PSD fraction, but are not necessarily enriched in the 
PSD fraction over other membrane fractions. 
There have been two approaches used to identify novel proteins in the PSD 
fraction. In one approach, antibodies against the fraction are generated and cDNA clones 
are obtained by screening expression libraries. This method has been of limited use 
because it results in a high rate of false positives at several steps. For example, the 
unization of mice with total PSD proteins selects for the most antigenic and not 
necessarily the most abundant proteins. Thus, it may target proteins that are minor 
contaminants of the PSD fraction. Also, expression library screening usually results in a 
number of false positives. Nonetheless, this approach does have the potential to identify 
relatively minor proteins in the PSD fraction that are associated with the synapse in vivo 
and have important functions. Proteins that have been identified in the PSD fraction using 
this method include SAP-97 (Muller et al., 1995) and dynamin (Walsh and Kuruc, 1992). 
A second approach to identify novel PSD proteins involves direct microsequencing 
and cloning of proteins from the PSD fraction. A common criticism of the use of the PSD 
fraction to determine its structural components is that non-PSD proteins may adhere to the 
PSD during homogenization. Our lab has determined that many of these nonspecifically 
bound, non-PSD proteins are likely to be removed by additional detergent washes. For 
example, I identified a 110 M>a protein in the PSD fraction that is extracted by N-octyl 
glucoside as hexokinase, a mitochondria1 enzyme and probably a contaminant of the PSD 
preparation (Apperson and Kennedy, 1993). Many proteins can be removed from the 
PSD fraction purified by one extraction with Triton-XI00 followed by an extraction with 
the relatively harsh detergent N-lauroyl sarcosinate (sarcosyl), originally used by the 
Cotman lab in their purification of the PSD fraction. We refer to the proteins that remain in 
the insoluble pellet after sarcosyl extraction as "core" proteins. Our recent work suggests 
that they are likely to be important structural components of the PSD (Figure 1.3). For 
example, the a subunit of CaMKII is enriched in the "core" fraction and has also been 
localized to the PSD by imuno-electron microscopy (Kennedy et al., 1990). Because of 
results like these, we have decided that we would increase our chance of identifying "real" 
components of the PSD by directly sequencing proteins that remain in the PSD fraction 
after multiple detergent extractions. 
Our laboratory has used this technique to identify two proteins that are tightly 
associated with the PSD fraction. The first is PSD-95 (Cho et al., 1992), a novel 
brain-specific protein with significant homology to the Drosophila discs-large protein (dlg, 
Woods and Bryant, 1991). The Cho et al. paper first identified three repeats in PSD-95 
and dlg that are now called PDZ domains (Kennedy, 1995). Like the a subunit of 
CaMKII, PSD-95 has been localized to the PSD by immuno-electron microscopy of 
synaptosomes (Hunt et al., 1996). The second protein we identified is the 2B subunit of 
the NMDA receptor,which we showed is the major tyrosine-phosphorylated protein in the 
PSD fraction (Moon et al., 1994). Both PSD-95 and NR2B remain associated with the 
sarcosyl-extracted PSD fraction. Recently, (Kornau et al., 1995) used a yeast two-hybrid 
screen to select proteins that associate with the unique C-terminal domains of the NMDA 
receptor type 2 subunits. This screen identified PSD-95 as a protein interacting with the 
"bait." The interacting regions of the two proteins were identified as the second PDZ 
domain of PSD-95 and the terminal seven or so amino acids of the NR2 subunits, all of 
which are homologous and comprise a motif termed tSXV (terminal SXV). Additionally, 
we have shown that NR2B and PSD-95 colocalize at synapses in dissociated hippocampal 
neuronal cultures. This specific and tight association may reflect a mechanism for 
clustering NMDA receptors in the postsynaptic membrane, one of the initial proposed 
functions of the PSD. 
Thus, I decided to probe further the function of the PSD through the molecular 
characterization of proteins in the PSD fraction. Since the time that I began my thesis 
work, our lab and others have identified likely candidates in the PSD fraction for receptor 
clustering (NR2BPSD-95), signal transduction (CaMKI1) and structural elements 
(dystrophin, fodrin, tubulin and actin), but no strong candidates for adhesion molecules. 
Evidence of adhesion molecules at the synapse 
Adhesion between presynaptic and postsynaptic membranes is another proposed 
function of the PSD that remains to be tested. Most of what we know about adhesion 
molecules in the nervous system comes from studies of neurite outgrowth and axon 
pathfinding during development. The majority of adhesion molecules involved in these 
processes fall into three classes: the imunoglobulin (Ig) superfamily, the cadherin 
family, and the integrin family of proteins. The Ig and cadherin families are thought to 
promote adhesion between neurons by homophilic interactions whereas the integrin family 
promotes adhesion by binding to extracellular matrix molecules. 
At the synapse, a dense-staining material fills the synaptic cleft and has been 
proposed to contain adhesion and extracellular matrix molecules. There is a very tight 
correlation between sites of vesicle docking at the presynaptic membrane and sites of thick 
postsynaptic densities beneath the postsynaptic membrane. This specificity of interaction 
between axon terminal and dendritic spine suggests a heterophilic recognition between a 
presynaptically expressed adhesion molecule and a postsynaptic partner. However, despite 
the considerable indirect evidence for adhesion molecules in the synaptic cleft, little is 
known about the primary structure of proteins that reside there. 
One possible protein pair located in the synaptic cleft is the neurexin/neuroligin 
binding pair. Neurexins are a large family of related proteins that were identified as 
receptors for a-latrotoxin, a toxin that binds to presynaptic nerve terminals and triggers 
massive transmitter release (Ushkaryov et al., 1992). Neurexins contain extracellular EGF 
repeats and laminin A-like domains as well as a single serine/threonine-rich domain that 
may serve as an attachment site for 0-linked sugars. Immunofluorescent labelifleg of 
neurexin in the brain has shown that it colocalizes with the synaptic marker synaptophysin. 
The neuroligins have been identified as specific binding partners for some forms of 
neurexins and are enriched in brain synaptic membrane fractions (Ichtchenko et al., 1995, 
and Ichtchenko et al., 1996). Neuroligins are transmembrane proteins that contain an 
esterase domain and a potential 0-linked sugar attachment site in the extracellular region of 
the protein. 
At least two other adhesion molecules have been reported to be localized at 
synapses by electron microscopy. First, a monoclonal antibody to the extracellu1;u domain 
of N-cadherin densely stains the synaptic cleft in the developing optic tectum (Yamagata et 
al., 1995). However, poor tissue preservation in these sections raises the possibility of 
nonspecific staining. Second, an antibody specific for the 180 kDa form of N-C 
(N-CAM 180) has been reported to stain approximately 30 to 40 % of all postsynaptic 
densities in fixed brain tissue (Persohn et al., 1989). However, the N-CAM 180 protein is 
not enriched in PSD fractions, indicating that the synaptic N-CAM may not form 
detergent-resistant bonds with proteins of the PSD fraction. In both of these studies, 
bound antibodies were detected with a horseradish peroxidase reaction product that can 
precipitate artifactually on the postsynaptic density and membranes, and is very similar to 
the normal electron-dense appearance of PSDs. 
Evidence of adhesion molecules in the synaptosome and PSD fractions 
Electron micrographs of non-lysed and lysed synaptosomes show a loss of some 
of the densely staining cleft material present in the intact brain, suggesting that some of the 
extracellular matrix or adhesion molecules spanning the cleft may be lost during 
homogenization of the brain. In certain sections it is possible to discern thin "threads" of 
electron-dense material joining the pre and postsynaptic membranes (highlighted in Figure 
1.4 with transparent yellow lines). In Chapter 3, I describe the cloning of a novel adhesion 
molecule-like protein from the PSD fraction that we have named densin- 180. Densin- 180 
contains an arrangement of domains found in other adhesion molecules, most notably, 
leucine rich repeats (LRRs) and an 0-sialomucin domain. Not only is this the first 
molecule of its kind cloned from mammalian brain, it is also the first potential adhesion 
molecule directly identified as enriched in the PSD fraction. Perhaps proteins in other 
systems that contain similar adhesion motifs can provide clues about a mechanism of 
adhesion mediated by densin- 180 at the synapse. 
The LRR family of proteins 
The leucine-rich-repeat family contains a large number of proteins with a wide 
range of functions, including cell adhesion, signal transduction, and gene expression. The 
leucine-rich repeats (LRRs) of different proteins vary in length from 20 to 29 amino acids, 
with 24 the most common. The only generalization that can be made about the function of 
LRRs in this family of proteins is that the LRR region forms specific, tight interactions 
with binding partners. The recent crystal structure of ribonuclease inhibitor (RI) bound to 
ribonuclease A provides a structural basis for this general function of LRR domains (Kobe 
and Deisenhofer, 1995). Ribonuclease inhibitor is made up almost entirely of leucine-rich 
repeat units that form a f k x  structure. This structure is horseshoe-shaped and binds 
RNAse along the concave surface formed by the P-sheets of the LRR (see Figure 1.5A). 
When the inhibitor is bound to it, the RNAse surface is no longer accessible to the solvent. 
RI changes its conformation upon binding RNAse by an elastic alteration of the entire 
structure that appears to rely on the flexibility of the LRR repeats. This flexibility is likely 
to be important for the tight protein-protein binding between RI and RNAse (Ki of 6.7 x 
10-l4 M). 
The LRRs of RI are among the longest in the family (28-29 residues). 
Nevertheless, based upon the crystal structure of RI, Kajava et al., 1995, generated a model 
of the three-dimensional structure of the more typical 24 residue LRRs of the ligand 
binding domain of the thyrotropin receptor (TSHR). They constructed their model based 
upon a consensus sequence generated from proteins with more typical 20-24 amino acid 
LRRs. The predicted structure of the 8 LRRs in TSHR has a less curved structure than the 
LRRs of RI due to the shorter a helices and slightly different conformations of the a-p and 
@-a connecting loops (Figure 1.5B). This confirmation also predicts a larger surface area 
available for ligand binding. 
Cell surface proteins make up the largest subfamily of LRR proteins. Some 
LRR-receptors are thought to bind ligand via their LRR domains to mediate signal 
transduction in the cytosol. Examples include the trophic factor receptors trk and trk B 
(Schneider and Schweiger, 199 I), as well as the plant receptor serine/theonine kinase 
protein TMK1 (Chang et al., 1992). Other LRR glycoproteins are involved in adhesion. 
For example, chaoptin is a PI linked protein that was identified as a surface protein in the 
developing imaginal eye disc and adult eye of Drosophila. Chaoptin mediates homophilic 
adhesion in vitro (Krantz and Zipursky, 1990). Lastly, some of the LRR glycoproteins 
have potential roles in both adhesion and signal transduction. The transmembrane receptor, 
toll, was identified as a Drosophila gene involved in establishing the dorsal-ventral body 
axis [Hashimoto et al., 1988). The extracellular domain of toll contains a large number of 
LRRs and the cytoplasmic region contains an interleukin-1 (IL-1) domain. Toll has been 
shown to promote heterotypic cell adhesion (Keith and Gay, 1990) and may mediate signal 
transduction through the IL-1 domain. 
There is some evidence that LRR molecules are important in the development of 
the nervous system. Most of this evidence comes from genetic studies of Drosophila 
development in which several LRR-containing proteins have been implicated in axon 
pathfinding and target specificity (reviewed in Hortsch and Goodman, 1991). Connectin is 
a PI-linked adhesion molecule that mediates homotypic adhesion in vitro and is expressed 
both on motoneuron axons and on the target muscles they innervate (Meadows et al., 
1994). Only a few LRR-containing proteins have been identified in mammalian neurons. 
They include the oligodendrocyte-myelin glycoprotein (Mikol et al., 1990) and a new 
protein, NLRR-3 (Taniguchi et al., 1996). However, a role for these proteins in adhesion 
has not been established. 
The sialomucin family of proteins 
A new subfamily of glycoproteins has been recognized that contains mucin-like 
regions in the extracellular domains (reviewed in Strous and Dekker, 1992). The 0-linked 
glycose groups attached to these domains often contain large amounts of sulfates or sialic 
acid that are necessary for protein function. These mucins are either secreted or 
membrane-bound. Secreted mucins can form a protective gel on the surface of some cell 
types. For example, the mucous layer in the intestine is composed largely of secreted 
mucins that act as a selective barrier to diffusion. 
Membrane proteins that contain mucin domains have also been well characterized. 
CD34 and CD43 are examples of sialoglycoproteins that are involved in cell signaling in 
the immune system. These proteins have a role in the normal growth and differentiation of 
stem cells into mature leukocytes. In carcinoma cells, epiglycanin, epitectin and ascites 
sialoglycoprotein- 1 are sialomucins that may be involved in the progression of cancer. 
In the nervous system, a number of proteins have been described with mucin-like 
serine/threonine rich domains that are potential sites of 0-glycosylation. Indirect evidence 
indicates that neurexins are sialomucins because they contain a mucin-like sequence and are 
sensitive to neuraminidase and 0-glycanase digestion. Neuroligins also have a number of 
clustered serines and threonines, but their glycosylation has not been studied. 
Sialoglycoproteins that are expressed in the brain include the cellular prion protein (Oesch 
et al., 1985) and cranin, a brain form of alpha-dystroglycan (Smalheiser and Kim, 1995). 
The 0-linked sugar domains in these and other proteins have been proposed to 
mediate several different functions. First, mucins contribute to the formation of a 
protective layer on the surface of cells that repels other proteins and cells. For example, the 
glycocalyx is composed entirely of mucins that form a protective surface extending 100 
Angtroms from the erythrocyte membrane (Viitala and Jamefelt, 1985). Next, the mucin 
domain of CD4.3 has been shown to form an extended rod-like structure and similar 
domains in other proteins have been proposed to function by extending a binding domain 
into the extracellular space (reviewed in Jentoft, 1990). Lastly, the 0-linked sugars serve 
as a site for specific transient binding by a new family of adhesion proteins, the selectins 
(summarized in Figure 1.6). 
Selectins specifically interact with carbohydrates in a calcium-dependent manner 
through a C-type lectin domain (reviewed in Cumrnings and Srnith, 1992). There are three 
known members of this family, P-selectin, E-selectin, and L-selectin (found in platelets, 
endothelid cells and leukocytes, respectively). Selectins mediate the adhesion responsible 
for cell rolling during the inflammation response. During inflammation, leukocytes are 
recruited from the circulating blood by binding to the surface of the blood vessel wall. The 
phenomenon of rolling occurs in conditions of high shear force because transient contacts 
are made with endothelid cells of the blood vessel. The selectins are thought to mediate 
these transient contacts by the rapid formation and dissociation of bonds with a specific 
ligand on the blood vessel. The high on and off rates of these interactions are not only 
important for function of these molecules in transient adhesion, but are also responsible for 
the overall low affinities reported for selectin interactions (Kd of M has been reported 
for E-selectin binding to carbohydrate in van der Merwe and Barclay, 1994). 
Adhesion mediated by the platelet glycoprotein Ib-IX complex 
The platelet glycoprotein Ib-IX complex also mediates adhesion in conditions of 
high shear forces generated in the blood (reviewed in Williams et al., 1995 and Roth, 
1991). GPIba is the largest member of this complex and binds to von Willebrand factor to 
mediate adhesion of platelets to the blood vessel wall. Ligand binding is mediated through 
an extracellular N-tenninal LRR domain (Figure 1.7A). The LRR domain is followed by a 
sialomucin domain that extends the ligand binding domain from the cell surface. On the 
cytoplasmic side, GPIba binds to actin binding protein (ABP) and may mediate 
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cytoskeletal rearrangement in response to ligand binding on the surface. Von Willebrand 
factor (vWF) binding to GPIba initiates a series of signal transduction events such as 
phospholipid metabolism, activation of protein kinases, and elevation of cytoplasmic 
calcium. The binding of vWF to GPIba (Kd of 1.2 nM; from Meyer et al., 1993) is likely 
to involve high rates of association and dissociation and be resistant to tensile stress. 
Interestingly, platelets move slowly along the surface of immobilized von Willebrand 
factor in the presence of high shear forces in a manner reminiscent of leukocyte cell rolling 
on the endothelium (Savage et al., 1996). 
Analysis of the GPIb complex by electron microscopy reveals a rod-like structure 
corresponding to the mucin domain of GPIba that connects the globular ligand binding and 
cytoplasmic domains (Figure 1.7B) (Fox et al., 1988). This domain is similar to the mucin 
domain of CD43 that extends to 2.5 Angstroms per residue (Cyster et al., 1991). 
Summary 
In this thesis, I describe the characterization of densin- 180, a brain protein that 
contains both leucine-rich and sialomucin domains and may mediate adhesion at the 
synapse via mechanisms that are similar to GPIba adhesion. Based on the structure of 
CD43, the 80 amino acid mucin domain of densin- 180 has the potential to extend 20 nm 
from the surface of the cell. At the synapse, the filamentous structures that extend the 10 to 
20 nm between the pre and postsynaptic membranes may correspond to the sidomucin 
domain of densin-180. By analogy with the adhesion mediated by GPIba, the adhesion 
mediated by densin- 180 might be expected to withstand the shear forces generated during 
the brain homogenization used to make synaptosome and PSD fractions. Additionally, the 
type of transient and specific adhesion that has been described for GPIbcl could be used by 
densin- 180 to mediate the dynamics of neurite outgrowth, synapse formation and synaptic 
plasticity in the brain. 
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FIGURE: LEGENDS 
Figure 1.1. Serial electron micrographs through a dendritic spine. Each of the eight 
micrographs contains a section through the dendritic spine and its corresponding 
presynaptic bouton. A non-docked vesicle (arrow) in the presynaptic bouton is shown in 
(A). Characteristic docked vesicles (curved arrows) across from the PSD (arrowhead) are 
shown in (B), (E) and (G). The synaptic cleft (wiggly arrow) contains dense staining 
material (C). Extracellular space that does not have dense staining material is shown with 
an arrow in (F). Arrowhead in (H) denotes the gray edge of the plasma membrane. 
Astrocytic processes are shown in consecutive sections (B) through (H) with a star. From 
Harris and Sultan, 1995. 
Figure 1.2. Electron micrographs of synaptosome and postsynaptic density fractions at 
different stages in the purification. A single synaptosome (A), lysed synaptosome (B), and 
postsynaptic density after sarcosyl extraction (C) from each fraction is shown. From 
Cotman et al., 19'74. 
Figure 1.3. Protein composition of detergent-extracted PSD fractions. PSD fractions were 
obtained after extraction of synaptosomes once with Triton X-100 (One Triton), twice with 
Triton X- 100 (Two Triton) or once with Triton X- 100 and once with sarcosyl (One Triton 
+ Sarcosyl) and pelleting at 201,800 x g for 1 hour. Synaptosome and PSD fractions were 
separated by SDS-PAGE and stained with Coomassie blue. The location of actin, tubulin, 
fodrin, PSD-95, hexokinase and the a and B subunits of the CaMKII are identified on the 
right. Molecular weight markers are shown at the left. From Cho et al., 1992. 
Figure 1.4. Electron micrographs of non-lysed and lysed synaptosomes. Non-lysed 
synaptosomes stained for PSD-95 are shown in (a). Lysed synaptosomes stained for 
synapsin I are shown in (b). In both cases, there are several examples of thin electron 
dense "lines" connecting the presynaptic and postsynaptic membranes (indicated with 
transparent yellow lines in right panels). Scale bar represents 100 nm. Adapted from Hunt 
et al., 1996. 
Figure 1.5. Structures of leucine-rich repeats. Two projections of the crystal structure of 
ribonuclease-bound ribonuclease inhibitor (RI) is shown in (A) and (B). The RI is green 
and the RNAseA is yellow. (B) is rotated 90° along the horizontal axis compared to (A). 
From Kobe and Deisenhofer, 1995. A model of the more typical 24 amino-acid 
leucine-rich repeats of thyrotropin receptor (TSHR) is shown in (C). The part of the 
structure that is conserved between RI and TSHR is shown in green and the modeled part 
of the structure is in blue. From Kajava et al., 1995. 
Figure 1.6. Summary of 0-glycosylated membrane proteins and their interactions with 
selectins. Several membrane glycoproteins drawn to scale are shown in (A). The 0- 
glycosylated regions of these proteins are represented as stiff, extended structures with a 
length of 2.5 Angtroms per amino acid residue. Globular regions are represented as 
spheres and the dotted line represents the extension of the erythrocyte glycocalix as 
estimated by Viitala and Jarnefelt, 1985. The low-density lipoprotein (LDL) receptor 
contains a total of 840 amino acids of which 48 are present in the 0-glycosylated regions. 
Decay accelerating factor (DM, 347 amino acids in length) contains 70 amino acids in the 
0-glycosylated domain. Leukosialin is a transmembrane sialoglycoprotein in which most 
of the extracellular domain is glycosylated. From Jentoft, 1990. A schematic of the 
interaction of selectins with mucins is shown in (B) drawn to scale. The dimensions of the 
PSGL- 1 (P-selectin glycoprotein ligand- 1) and CD34 are based on CD43 structure 
(Springer, 1994). The neutrophil membrane projection represents a microvillus, is not 
drawn to scale, and is actually larger than shown. From van der Merwe and Barclay, 1994. 
Figure 1.7. Structure of GPIba. (A) shows a schematic diagram of proteins in the GPIb- 
IX complex (from Williams et al., 1995). Disulphide linked GPIba and GPIbf3 associate 
non-covalently with a third subunit, GPIX. The extracellular domains of GPIbfi and GPIX 
contain a single leucine-rich repeat (LRR) and the extracellular domain of GPIba contains 
seven LRRs (shaded disks). The disulphide looped C-terminal cysteine rich domain is 
represented by a shaded block). The N-terminal von Willebrand factor binding domain of 
GPIba is extended from the membrane via the rod-like sialomucin domain which is 
extensively glycosylated (represented by black dots). Part (B) shows an electron 
micrograph of purified GPIb complex visualized using rotary shadowing (from Fox et al., 
1988). The globular portions of the dumbbell-shaped structure correspond to the 
cytoplasmic and vWF-binding domains of GPIb. The extended part of the structure 
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The major tyrosine-phosphorylated protein in the 
postsynaptic density fraction is N-methyl-D-aspartate 
receptor subunit 2B 
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ABSTRACT 
The postsynaptic density (PSD) is a specialization of the submembranous 
cytoskeleton that is visible in the electron microscope on the cytoplasmic face of the 
postsynaptic membrane. A subcellular fraction enriched in structures with the 
morphology of PSDs contains signal transduction molecules thought to regulate 
receptor localization and function in the central nervous system. We have purified a 
prominent tyrosine-phosphorylated glycoprotein of apparent molecular mass 180 
kDa, termed PSD-gpl80, that is highly enriched in the rat forebrain PSD fraction. 
The sequences of four tryptic peptides generated from the protein reveal that it is the 
2B subunit of the N-methyl- aspar art ate (NMDA) type glutamate receptor. We have 
confirmed the identity of PSD-gpl80 by showing that it reacts with antibodies 
raised against a unique fragment of the 2B subunit of the NMDA receptor. We also 
show that the 2B subunit is the most prominently tyrosine-phosphorylated protein 
in the PSD fraction based upon recognition by an anti-phosphotyrosine antibody. 
Two types of NMDA receptor subunits have been identified by molecular cloning 
(Nakanishi, S. (1992) Science 258,597-603). The single type 1 subunit is expressed 
throughout the brain and is necessary for formation of the receptor channel. The 
four type 2 subunits (2A, 2B, 2C, and 2D) are expressed in discrete brain regions, 
contain unusually long unique COOH termini, and confer distinct kinetic properties 
on NMDA receptors that contain them. Our findings suggest that, in the forebrain, 
NMDA receptor subunit 2B may serve to anchor NMDA receptors at the 
postsynaptic membrane through its interaction with the PSD. The prominent 
presence of tyrosine phosphate further suggests that the NMDA receptor may be 
regulated by tyrosine phosphorylation or that it may participate in signaling 
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through tyrosine phosphorylation and through its ion channel. 
Regulation of synaptic transmission by prior neural activity is an important 
mechanism of information processing in the central nervous system. Such regulation 
occurs in part through modulation of transmitter receptors in the postsynaptic membrane 
(1,2). Excitatory synapses in the central nervous system contain two major classes of 
postsynaptic glutamate receptors: a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
(AMPA)-type receptors generate the basal postsynaptic potential; whereas NMDA-type 
receptors display unique voltage-dependent activation properties and play a critical role in 
initiation of long-term potentiation, a form of synaptic plasticity believed to be important 
for formation of memories (3,4). 
The postsynaptic density (PSD) is a specialization of the submembranous 
cytoskeleton visible in the electron microscope that appears to represent a tight complex of 
postsynaptic junctional proteins (for a recent review see (5)). A subcellular fraction from 
rat forebrain called the PSD fraction is enriched in structures with the morphology of PSDs 
(6,7). AMPA receptor subunits are associated with the PSD fraction (8-10) and may be 
enriched there (8). The fraction also contains high-affinity glutamate binding sites with 
some of the pharmacological properties of NMDA receptor sites (1 I), as well as proteins 
that may participate in receptor regulation and in regulation of other forms of synaptic 
efficacy. These include the subunits of ~a~+/calmodulin-dependent protein kinase I1 (12- 
15), a src-like protein tyrosine kinase (16), a CAMP-dependent protein kinase anchoring 
protein (17), and PSD-95, a close homologue of the Drosophila discs-large tumor 
suppressor protein which participates in formation of septate junctions and growth control 
in developing flies (18). C?/calmodulin-dependent protein kinase 11 (19) and PSD-95 
(18) have been shown to be highly enriched in the PSD fraction and are associated with 
PSDs in situ as determined by imunocytochemical staining of brain synaptosomes (ref. 
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15 and C. Hunt, L. Schenker, and M.B.K., unpublished observation) reinforcing the notion 
that the major proteins of the PSD fraction represent a functional protein complex. 
Here we show that a 180 kDa glycoprotein highly enriched in the PSD fraction is 
subunit 2B of the NMDA receptor (NR2B). We show also that NR2B is the most 
prominently tyrosine-phosphorylated protein in the PSD fraction. 
Two distinct types of NMDA receptor subunits were identified recently by 
molecular cloning (20-22). Like most ionotropic receptors, NMDA receptors are 
composed of multiple subunits with homologous sequences (23,24). NMDA receptor 
subunit 1 (termed NRl) has a molecular mass (106 kDa) close to that of the subunits of 
the AMPA class of glutamate receptors. In contrast, the NMDA receptor subunits termed 
2A, 2B, 2C, and 2D are considerably larger, having molecular masses from 135 kDa to 
166 kDa. Their larger sizes result from long COOH-temini that are only distantly related 
to each other in sequence. Phosphorylation sites for protein kinase C have been localized to 
the extreme carboxyl terminus of the NR1 subunit (25), suggesting that the long COOH 
domains of the homologous type 2 subunits also extend into the cytosol where they could 
mediate additional regulation by phosphorylation (25,26). NR1 is expressed throughout 
the brain and is essential for formation of a receptor channel; whereas, the NR2 subunits 
are not essential for channel formation, have more restricted expression patterns, and 
appear to modulate receptor channel kinetics in different ways (22-24). The findings 
reported here suggest that NR2B associates tightly with the PSD structure and thus may 
mediate specific interactions with PSD proteins and other cytosolic proteins perhaps 
through tyrosine phosphorylated domains. 
MATERIALS AND METHODS 
Purification of PSD-gpl80. The crude PSD fraction (90 mgs; 3-5 mgs/ml) was 
prepared as previously described (18) by a modification of the method of Carlin et al. (7). 
The PSD fraction was extracted with 1% N-octylglucoside (NOG) at 4°C for 30 min with 
stirring. Insoluble material was pelleted by centrifugation at 200,000 g for 30 min at 4°C. 
The pellet (NOG-P) (2 mg/ml) was treated with Endogly cosidase F/N-g lycosidase F 
(Boehringer Mannheim) in 0.2% SDS according to the supplier's instructions. To purify 
individual proteins, the deglycosylated proteins (63 mgs) were fractionated on 60 
preparative 6% SDS polyacrylamide gels. Each gel was stained with 0.2% (w/v) 
Coomassie blue R-250 in 10 mM Tris-Cl (pH 8.0), 0.01% SDS for 30 min. Bands 
containing two proteins, PSD-gp 180 and a second protein termed PSD-up 180, were cut 
from the gels, pooled, and chopped into 3-5 mm pieces. Protein (approx. 400 yg each) 
was electroeluted from the pieces in an Elutrap device (Schleicher & Schuell) at 250 V in 
25 mM N-ethylmorpholine (pH 8.5), 0.01% SDS overnight at room temperature into 
approximately 6 ml of 0.5% SDS, 25 mM N-ethylmorpholine. Because the purified 
proteins still contained a small amount of bound Coomassie dye that interferred with 
determination of protein by the method of Peterson, protein was estimated after SDS-gel 
electrophoresis by comparison to a set of Coomassie stained BSA standards. 
Preparation of antibodies against the C-terminus of NR2B. Bacteriophage 
clones containing cDNA inserts encoding NR2B were selected from a hgtl 1 library 
(Clontech) by screening with an oligonucleotide sequence deduced from peptide sequence 
2 (Table I). A restriction fragment (PmlI to EcoRI) encoding 334 amino acids of the 
C-terminus of NR2B (from 1149 to the carboxyl terminus) was ligated into the pGEX-3X 
expression vector (Pharmacia). A GST fusion protein containing the NR2B fragment was 
expressed in E. coli, and purified from inclusion bodies by electrophoresis through a 6% 
SDS-polyacrylamide gel. The protein was visualized after soaking the gel in 0.25 M KC1. 
Bands containing the fusion protein were cut from the gel and used to immunize mice 
from which polyclonal ascites fluid was prepared as described by Ou et al. (27). 
Antibodies from the ascites fluid recognize a single band of approximately 180 kDa at 
1 :5,000 dilution on imunoblots of proteins from a rat brain homogenate (data not 
shown). Control ascites fluid generated without immunization with NR2B does not react 
with any proteins in the PSD fraction. 
Immunoblots with anti-NR2B and anti-phosphotyrosine. For the experiments 
described in Figs. 2 and 3, the crude PSD fraction was prepared as previously described 
(18)' except that 0.1 mM orthovanadate was included to inhibit dephosphorylation of 
tyrosine residues. Transfer to nitrocellulose and incubation with antibodies was carried out 
as described by Cudmore and Gurd (28). Antibody 4g10 against phosphotyrosine was 
purchased from Upstate Biotechnology Inc. (NY). Primary antibodies were visualized 
after incubation with alkaline-phosphatase-conjugated rabbit IgG according to the 
supplier' s instructions (Boehringer Mannheim). 
Immunoprecipitation. Crude PSD fraction (500 pg) prepared in the presence of 
0.1 mM orthovanadate was brought to 0.7% SDS and boiled for 3 min. The solution was 
adjusted to a final concentration of 10 mM Tris-C1 (pH 7.4), 1 mM EDTA, 150 mM 
NaC1, 1 % Triton X- 100, 1 % Sodium deoxycholate, 0.1 % SDS (RIPA buffer) in a final 
volume of 1 ml, Ascites fluid (a-NR2B or control) was added at 150  dilution, and the 
mixture was incubated for 4 hr at 4OC with mixing. The solution was cleared by 
centrifugation for 20 min at 12,000 rpm in an Eppendorf centrifuge at 4°C. Protein 
A-agarose beads (250 pl, Pierce Chemical Co.) washed in RIPA buffer were added to the 
supernatant and incubation was continued for an additional 4 hr. The beads were collected 
by centrifugation and washed 5 times with RIPA buffer. Sample solution for 
SDS-polyacrylamide gel electrophoresis was added and the mixture was boiled for 3 min. 
Beads were pelleted by centrifugation and a volume of the supernatant corresponding to 
100 pg of the original PSD fraction was applied to each lane of a 6% SDS gel. 
Analytical Methods. Except where noted, protein was measured by the method 
of Lowry (29) as modified by Peterson (30). SDS polyacrylamide gel electrophoresis was 
performed by the method of Laemmli (3 1). 
Results 
Purification of PSD-gpl80. A crude PSD fraction was isolated from rat 
forebrains as described under Materials and Methods. We investigated the proteins 
contained in a broad band at 180 kRa (Fig. 1) because they have previously been shown to 
contain tyrosine phosphate (32), to be phosphorylated by a calmodulin-dependent protein 
kinase (33), and to remain associated with the PSD fraction following extraction with the 
harsh detergent sarcosyl(18,34). Three proteins associated with this broad band were 
resolved from one another. The first was selectively removed by extraction of the PSD 
fraction with 1 % N-octyl glucoside (NOG; Fig. 1A). Enzymatic deglycosylation shifted 
the electrophoretic mobility of a second protein band (PSD-gp180) to an apparent 
molecular mass of 160 kDa and did not alter the mobility of a third protein band 
(PSD-upl80) (Fig. 1A). We electroeluted several hundred pgs of each individual protein 
from preparative SDS gels for sequencing as described under Materials and Methods. 
Each electroeluted protein appeared as a single band upon SDS-gel electrophoresis (Fig. 
1B). 
Sequencing and identification of NR2B. Purified PSD-gpl80 (approx. 300 pg) 
was trypsinized as previously described (1 8,35) and four tryptic peptides were purified 
and sequenced (Table I). A search of the GenBank data base performed with the BLAST 
network service through the National Center for Biotechnology Information revealed that 
all four sequences are present in the 2B subunit of the rat brain NMDA receptor (NR2B) 
(21,22,36,37). Sequences 2 through 4 are unique to NR2B; sequence 1 is found in all 
four type 2 NMDA receptor subunits. 
Identification of NR2B by antibody binding. We raised antibodies against a 
portion of the carboxyl terminal domain that is unique to NR2B to verify that PSD-gp180 
is NR2B. Immunoblots of the NOG-treated PSD fraction were probed with these 
antibodies and revealed that NR2B was present at an apparent molecular mass of 180 kDa 
before deglycosylation. Its mobility shifted completely to an apparent molecular mass of 
160 kDa after deglycosylation (Fig. 2). The a-NR2B antibodies also recognized purified, 
electroeluted PSD-gp 180 protein. 
Reaction of NR2B with anti-phosphotyrosine antibodies. It was previously 
reported that a 180 kDa glycoprotein from the PSD fraction is a tyrosine-phosphorylated 
protein (30). To test whether NR2B contains tyrosine phosphate, blots of the PSD fraction 
were probed with monoclonal antibody 4g10 against phosphotyrosine (Fig. 2). The major 
tyrosine-phosphorylated protein band in the PSD fraction comigrated at 180 kDa with 
NR2B and shifted to an apparent molecular mass of 160 kDa after deglycosylation (lanes 4 
and 3, in parallel with NR2B (lanes 1 and 2). In addition, purified, electroeluted 
PSD-gp180 reacted with the anti-phosphotyrosine antibody (lane 6). Preabsorption of the 
anti-phosphotyrosine antibody with 2 mM phosphotyrosine eliminated staining of the 180 
and 160 kDa bands as expected; whereas preabsorption with phosphoserine or 
phosphothreonine did not reduce the staining (data not shown). To eliminate the possibility 
that a distinct protein comigrating with PSD-gp 180 might contain the tyrosine phosphate, 
we imunoprecipitated NR2B from the PSD fraction after solubilization and found that 
the immunoprecipitated protein contains phosphotyrosine (Fig. 3). Indeed, 
imunoprecipitation from the solubilized PSD fraction of nearly all the protein reacting 
with anti-NR2B antibodies removed over two-thirds of the anti-phosphotyrosine 
immunoreactivity at 180 kDa (data not shown). Taken together, the data in Figs. 2 and 3 
demonstrate that NR2B is the most highly tyrosine-phosphorylated protein in the PSD 
fraction based upon recognition by the anti-phosphotyrosine antibody. 
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Enrichment of NR2B in the PSD fraction. If NR2B is specifically associated 
with the PSD, it should be highly enriched in the PSD fraction, as are two other proteins 
previously identified as significant components of the PSD, the cc subunit of 
~a~+/calmodulin-dependent protein kinase I1 and PSD-95 (15, 18). To assess the level of 
enrichment of NR2B in the PSD fraction, we prepared imunoblots of rat forebrain 
homogenates, synaptosomes, and three different PSD fractions extracted with successively 
harsher detergent washes, probing with anti-NR2B antibodies (Fig. 4). NR2B was highly 
enriched in the PSD fractions, appearing approximately ten-fold more concentrated than in 
synaptosomes (compare lanes 2,4, and 5),  and 30 to 50-fold more concentrated than in the 
homogenate (compare lanes 1,4, and 5). 
DISCUSSION 
We have shown that NR2B is significantly enriched in the PSD fraction and is the 
most highly tyrosine-phosphorylated protein present there. The latter conclusion is based 
upon the assumption that antibody 4g10, which was raised against a phosphotyramine 
conjugate, reacts uniformly with tyrosine-phosphorylated proteins. This assumption is 
supported by studies demonstrating that 4g10 binds to a broad range of tyrosine- 
phosphorylated proteins on immunoblots, although differences in the affinities of 4g10 for 
tyrosine-phosphorylated proteins have not been strictly ruled out (38). NR2B may be 
identical to the tyrosine-phosphorylated protein termed gp 180 described by Gurd (32); 
however, we have not compared it directly with the protein purified by his protocol. 
The concentration of NR2B in the PSD fraction is higher than that of NR2A which 
is also expressed in the forebrain (22). NR2A would be expected to comigrate on SDS 
gels with NR2B because they have nearly identical molecular masses. However, our 
peptide sequences (Table I) did not match any unique to NR2A, indicating that it is absent 
or present in considerably lower quantity than NR2B. In addition, more than 2/3 of the 
protein migrating at 180 kDa was immunoprecipitated by a specific anti-NR2B antibody. 
Nevertheless, the small amount of tyrosine-phosphorylated protein remaining at the 180 
kDa position of SDS gels after immunoprecipitation of NR2B may be NR2A. The 
relatively high concentration of NR2B in the PSD fraction indicates either that it is 
expressed at higher levels than NR2A, or that it binds more avidly to PSD proteins and 
therefore remains in the PSD fraction during the detergent extraction that removes other 
synaptic membrane proteins. If the latter is true, we suggest that NR2B may anchor 
NMDA receptors in the postsynaptic membrane through its association with PSD proteins. 
Two potential regulatory roles for tyrosine phosphorylation of NR2B, which are 
not mutually exclusive, are suggested by studies of other membrane receptors. Agrin, a 
protein released from motor neuron terminals, induces clustering of acetylcholine receptor 
subunits at postsynaptic sites (39). Agrin also induces tyrosine phosphorylation of the P- 
subunit of the chick acetylcholine receptor (40). The tyrosine phosphorylation precedes 
receptor clustering; furthermore, agents that block the tyrosine phosphorylation also block 
agrin-induced receptor clustering, indicating that tyrosine phosphorylation is a critical part 
of the clustering mechanism in chick muscle. Thus, by analogy, it is possible that tyrosine 
phosphorylation of NR2B may catalyse clustering of NMDA receptors. 
An intriguing possibility is that the tyrosine phosphorylation may permit interaction 
of the NMDA receptor with proteins that contain src-homology-2 domains (termed SH2 
domains; 4 I), creating an assembly point for cytosolic signal transduction complexes (42). 
For example, it was recently demonstrated that binding of growth factors to receptor 
tyrosine kinases results in the formation of a complex between autophosphorylated 
tyrosine residues in the cytoplasmic tales of the receptors and SH2 domains contained in a 
protein termed Grb2 (43). Formation of this complex leads to activation of the Ras 
GTP-binding protein. Activated Ras then catalyzes, through a protein lunase cascade, 
activation of MAP lunase. Formation of such complexes might permit the NMDA 
receptor to participate in similar signal transduction pathways, and could underlie the recent 
observation that activation of NMDA receptors results in phosphorylation and activation of 
MAP kinase in hippocampal neurons (44). 
It will be important to localize in the NR2B sequence the sites of tyrosine 
phoshorylation and the domains of interaction with PSD proteins. These studies may help 
to clarify the functional significance of the unusually long carboxyl terminal domains of the 
type 2 NMDA receptor subunits. 
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FIGURE LEGENDS 
Table 1. Peptides were sequenced by the Caltech Applied Microsequencing Facility on an 
Applied Biosystems automatic sequencer. Initial yields were 41,3,28, and 23 pmoles for 
sequences 1 through 4, respectively. The sequence numbering for NR2B is based upon 
the numbering of the protein product of the cDNA described under accession number 
M9 1562 in the GenBank database. At the position marked X in sequence 1, we obtained 
no identifiable amino acid derivative; this residue is asparagine (N) in NR2B. In sequence 
2, the last residue was identified as aspartate (D), whereas it is asparagine (N) in NR2B. 
Deadat ion of the tryptic peptide may have caused this discrepancy. 
Figure 1. Purification of PSD-gp 180. A, Separation of three protein bands with apparent 
molecular masses of 180 kDa. A crude PSD fraction (PSD) was extracted with 
N-octylglucoside (NOG) as described under Material and Methods. One of the 180 kDa 
proteins (*) was solubilized during the extraction (NOG-S); two others (<, PSD-uplX0; C ,  
PSD-gp 180) remained associated with the NOG-insoluble pellet (NOG-P). Treatment of 
the pellet with a mixture of endoglycosidases shifted the mobility of PSD-gp 180; the two 
proteins were then separable by SDS polyacrylamide gel electrophoresis (NOG-P 
Endogly). Proteins in each fraction were separated by electrophoresis on a 6% SDS gel 
and stained with Coomassie Blue. B , Electroeluted PSD-gp 180 and PSD-up 1 80. After 
deglycosylation of the NOG-insoluble pellet, PSD-up 180 and PSD-gp 180 were purified to 
near homogeneity by electroelution from preparative SDS gels as described under 
Materials and Methods. A 2 pg aliquot of each protein was electrophoresed in a 6% SDS 
gel and stained with Coomassie Blue. Molecular size standards (in kilodaltons) are at left. 
Figure 2. Reaction of proteins in the PSD fraction with a-NR2B and a-phosphotyrosine 
antibodies. The PSD fraction before (Endogly -) and after (Endogly +) deglycosylation (20 
pg), and purified electroeluted PSD-gp180 (0.2 pg) were probed with antibodies raised 
against NR2B (a-NR2B, 1:5,000), with antibodies against phosphotyrosine (a-P-Tyr; 
4g10, 1:2,000), and with control ascites fluid (a-NR2B control; 1:5,000) as described 
under Materials and Methods. Lanes 1, 2,4,5,7, and 8 contained NQG-treated PSD 
fractions; lanes 3,6, and 9 contained electroeluted PSD-gp 180 (purified in the absence of 
orthovanadate). Molecular size standards (in kilodaltons) are at left. 
Figure 3. Reaction of imunoprecipitated PSD-gp 180 with anti-phosphotyrosine 
antibody. PSD-gp 180 protein was imunoprecipitated from the crude PSD pellet 
(prepared in the presence of orthovanadate) with anti-NR2B antibodies as described under 
Materials and Methods. Proteins imunoprecipitated by anti-NR2B (lanes marked 
a-NR2B and a-P-Tyr), and proteins imunoprecipitated by the control ascites fluid (lanes 
marked Control) were probed with anti-NR2B antibodies (lanes marked a-NR2B and 
a-NR2B Control) or anti-phosphotyrosine antibody (lanes marked a-P-Tyr and a-P-Tyr 
Control) as described in Fig. 2. Molecular size standards (in kilodaltons) are at right. 
Figure 4. Enrichment of PSD-gp180 in the PSD fraction. Fifty pgs each of rat forebrain 
homogenate (Horn) and synaptosomes (Syn) (lanes 1 and 2); and 5 pgs each of crude PSD 
fraction (IT), PSD fraction extracted twice with 0.5% Triton X-100 (2T), and PSD fraction 
extracted once with Triton X-100 followed by 3% sarcosyl (IT + S) (lanes 3-6) were 
electrophoresed in a 6% SDS gel and transferred to nitrocellulose. The blots were probed 
with mouse polyclonal anti-NR2B antibody as described in Fig. 2. Forebrain homogenate, 
synaptosomes, and detergent extracted PSD fractions were prepared as previously 
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ABSTRACT 
We purified an abundant protein of apparent molecular mass 180 kDal from the 
postsynaptic density fraction of rat brain and obtained the amino acid sequences of three 
tryptic peptides generated from the protein. The sequences were used to design a strategy 
for cloning the cDNA encoding the protein by the polymerase chain reaction. The open 
reading frame of the cDNA encodes a novel protein of predicted molecular mass 167 kDal. 
We have named the protein densin- 180. Antibodies raised against the predicted amino and 
carboxyl sequences of densin- 180 recognize a 180 M)al band on immunoblots that is 
enriched in the postsynaptic density fraction. Imunocytochemical localization of 
densin- 180 in dissociated hippocampal neuronal cultures shows that the protein is highly 
concentrated at synapses along dendrites. The message encoding densin- 180 is 
brain-specific and is more abundant in forebrain than in cerebellum. The sequence of 
densin- 180 contains 17 leucine-rich repeats, a sialomucin domain, an apparent 
transmembrane domain, and a PDZ domain. This arrangement of domains is similar to 
that of several adhesion molecules, in particular GPIba which mediates binding of platelets 
to vonwillebrand factor. We propose that densin-1 80 participates in specific adhesion 
between presynaptic and postsynaptic membranes at glutamatergic synapses. 
INTRODUCTION 
Glutamatergic synapses are likely to be important for information storage in the 
brain, yet until recently, little was known about the protein machinery at the postsynaptic 
membrane that is likely to function in adhesion, neurotransmitter receptor clustering and 
signal transduction at the synapse. Molecules important for these functions are likely to be 
found in the postsynaptic density (PSD), an electron-dense thickening just beneath the 
postsynaptic membrane. Our lab and others have focused on the characterization of 
proteins found in the PSD fraction. The PSD fraction is prepared after detergent extraction 
of synaptosomes (Cotman et al., 1974, Cohen et al., 1977, and Carlin et al., 1980). A 
common criticism of characterizing proteins of this fraction is that non-PSD proteins may 
adhere to the PSD during homogenization. To avoid this possibility, we have concentrated 
on studying proteins that remain associated with the PSD fraction after extraction with the 
relatively harsh detergent N-lauroyl sarcosinate (sarcosyl). We refer to the proteins that 
remain in the insoluble pellet after sarcosyl extraction as "core" PSD proteins. 
Our lab previously identified three "core" PSD proteins that have potentially 
important functions at the synapse. First, the a subunit of the type II calcium/calmodulin 
dependent protein kinase (CaMKII) is enriched in the "core" fraction and has also been 
localized to the PSD by imuno-electron microscopy (Kennedy et al., 1983). This 
enzyme is likely to mediate signal transduction in response to calcium influx at the synapse 
and is important in synaptic plasticity. A second PSD protein is PSD-95 (Cho et al., 
1992), a novel brain-specific protein with significant homology to the Drosophila 
discs-large protein (dlg), (Woods and Bryant, 1991). Cho et al. identified three repeats in 
PSD-95 and dlg that are now called PDZ domains. Like the a subunit of CaMKII, 
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PSD-95 has been localized to the PSD by immuno-electron microscopy of synaptosomes 
(Hunt et al., 1996). The third core PSD protein that we identified is the 2B subunit of the 
NMDA receptor (NR2B),which we showed is the major tyrosine phosphorylated protein 
in the PSD fraction (Moon et al., 1994). Recently, PSD95 has been shown to bind directly 
to NR2B in vitro, and NR2B and PSD-95 colocalize at synapses in dissociated 
hippocampal neuronal cultures (Komau et al., 1995). This may reflect a mechanism for 
clustering NMDA receptors in the postsynaptic membrane. 
The PSD has been proposed to mediate adhesion between the pre and postsynaptic 
membranes. A dense material fills the synaptic cleft and has been proposed to contain 
adhesion and extracellular matrix molecules. There is a very tight correlation between sites 
of vesicle docking at the presynaptic membrane and sites of thick postsynaptic densities 
beneath the postsynaptic membrane that is likely to be mediated by adhesion molecules. 
Here, we describe the cloning of densin- 180, a "core" PSD protein which has 
characteristics of a synaptic adhesion molecule. 
MATERIALS AND METHODS 
Purification of densin-180 and sequencing of tryptic peptides 
The crude PSD fraction was prepared as described previously (Cho et al., 1992), 
by a modification of the method developed in Carlin et al., 1980. The densin-180 protein 
was purified as described in Moon et al., 1994 (previously termed PSD-up 180). Briefly, 
63 mg of detergent-extracted, deglycosylated PSD proteins were fractionated by 
electrophoresis on 60 preparative 6% SDS-PAGE gels. The densin- 180 protein band was 
cut from each gel. Gel pieces were pooled, chopped into 5 mm pieces, and electroeluted 
N-ethyl morpholine, pH8.5 / 0.1% SDS at 250V in an Elutrap device 
(Schleicher & Schuell). The electroeluted protein (1.2 mg) was fractionated on a second 
set of 8 preparative 6% SDS-PAGE gels, transferred to nitrocellulose, and trypsinized as 
previously described (Aebersold et al., 1987). The trypsinized densin- 180 protein was 
concentrated to 0.4 nil and fractionated on a C4 high performance liquid chromatography 
(HPLC) column with a gradient of 3.5% to 73.5% acetonitrile in 0.1% trifluoroacetic acid. 
We hand-collected fractions of 0.1 to 1.0 ml corresponding to the elution of major peaks of 
absorbance at 280nm. Most of the major peaks were not single peptides and were further 
fractionated on a second C 18 HPLC column. Peak fractions were again collected by hand, 
flash frozen in liquid nitrogen, concentrated to 50-100 p1, and submitted to the Caltech 
Biopolymer Analysis Facility for peptide sequencing on an ABI automated gas phase 
sequencer. Amino acid sequences were obtained from seven of these samples with initial 
yields of 1-25 pmoles. 
Molecular cloning of densin-180 
Degenerate oligonucleotide primers were designed based on the three unique 
peptide sequences, synthesized on an ABI automated oligonucleotide synthesizer, and used 
as primers to amplify 5 week old rat forebrain cDNA by the polymerase-chain reaction 
(PCR) (Saiki et al., 1988). The cDNA was prepared from mRNA with the "First Strand 
cDNA" kit purchased from Clontech. The PCR reactions contained 0.2 pM each of sense 
and antisense primer, 2.5 mM each of dATP, dCTP, dGTP and dTTP (Boehringer 
Mannheim), 3.75 ng/pl cDNA, 125 mUIp1 Taq polymerase (Boehringer Mannheim), 1X 
Taq polymerase buffer (supplied with enzyme) and 0.5 mM extra MgC12. PCR products 
from large-scale reactions (100 p1) were purified by agarose gel electrophoresis, inserted 
into the TA plasmid supplied with the TA cloning kit (InVitrogen), and the plasmid was 
amplified by growth in E. coli. We sequenced the ends of each cloned PCR product by 
priming with oligonucleotides complementary to the M13 and T7 promoter sites in the TA 
plasmid. This permitted us to check which PCR products encoded the entire sequence of 
the original pair of peptides, including those amino acids that were not encoded in the 
original PCR primers. The sequence of the ends of one 1.2 kb product encoded the 
complete sequences of peptides 1 and 3. This product was purified by agarose gel 
electrophoresis, labeled with 3 2 ~  according to the "Random Primed DNA Labeling Kit" 
(USB), and used to screen a hZapn cDNA library prepared from 13 to 16 day old rat 
brains (Snutch et al., 1990, PNAS 87:339 1-3395, generously provided by TSnutch). 
Positive cDNA clones were plaque purified, then excised from hZapII with the 
E X A ~ ~ ~ ~ ~ ~ ~ / S O L R ~  system (Stratagene). The cDNA inserts were aligned and classified 
by restriction mapping. The cDNAs were ligated into the Bluescript plasmid (Stratagene) 
and sequenced by the method of Sanger (Sanger et al., 1977) according to the instmctions 
supplied with the "Sequenase" kit (USB). Initial sequencing from primers complementary 
to the Bluescript vector and to the PCR product revealed that clone 1.1 (5.2 kb) contained a 
5' ribosome binding site and initiation codon as well as a long open-reading frame 
including sequences encoding peptides 1 and 3. We sequenced exonuclease digests of 
clone 1.1 generated with the Erase-a-Base SystemTM (Promega) in both directions. Gaps 
in the sequence were filled in using oligonucleotide sequence primers. These primers were 
also used for the partial sequencing of other clones. Programs of the Wisconsin Package 
(Genetics Computer Group) and local programs at the Caltech Sequence Analysis Facility 
were used for sequence assembly, motif searches, and hydrophobicity analysis. 
Preparation of antibodies against densin-180 
We amplified two regions of the densin-180 cDNA encoding amino acids 466-958 
and 1374- 1495 by PCR, then cloned the products into the pGEX2T vector (Pharmacia 
Biotech, Inc.). The PCR products were sequenced to ensure that no mutations were 
introduced during the PCR reaction. The recombinant pGEX2T plasmids were grown in 
protease-deficient (lon-) E.Coli cultures at 30' C to an optical density of 0.5 at 600nm 
wavelength. A one liter culture was induced with 0.1 mM IPTG for 5 hours at 30' C and 
cells were pelleted by centrifugation at 5,000 g for 10 min. Pellets were resuspended in 40 
rnls of lysis buffer (20 mM sodium phosphate, pH 7.4 1 0.15 M NaCl I 1X protease 
inhibitor cocktail [Boehringer Mannheim] 1 0.5 mM DTT I 10 Ulml DNAse [Boehringer 
Mannheim]). The cells were lysed by sonication (2 minutes, level 6,50% pulse with 
Branson Sonifier 450), Triton X- 100 was added to I%, and the solution was mixed well. 
Lysates were cleared by centrifugation for 10 minutes at 10,000g. The supematant 
fractions were applied to a washed column containing 100 rng glutathione-agarose beads 
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(Sigma Chemicals). The column was washed twice with 40 mls PBS (20 
phosphate, pH 7.4 1 0.15 M NaC1) and the GST fusion proteins were eluted with 10 
reduced glutathione (Sigma Chemicals) / 50 rriM Tris-C1 pH 8 1 1 % TritonX- 100. The 
purity and concentration of the proteins in each eluted fraction was estimated by 
SDS-PAGE and by subsequent staining with Coomassie blue. 
The fusion protein containing amino acids 466-958 of densin- 180 was further 
purified by electrophoresis on 6% SDS-PAGE gels. The full-length fusion protein was 
visualized by soaking in 0.25 M KC1 and cut from the gel for injection into Swiss-Webster 
mice as an antigen for production of polyclonal ascites fluid (Ou et al., 1993). One mouse 
(M2) produced antibodies specific for densin- 180 when used for immunoblots, 
immunoprecipitations or immunostaining. This M2 ascites fluid (3 rnl) was purified by 
50% ammonium sulfate precipitation overnight at 4OC followed by centrifugation at 
10,000g for 10 minutes. The protein pellet was resuspended in 1 rnl of 25 
pH 7.5 and dialyzed against two changes of the same buffer overnight. Purified M2 
Ascites fluid was used for immunoblots of PSD fraction (at 1:3,000 dilution), 
immunoprecipitation from PSD fraction (at 1 : 10 dilution) and immunofluorescent staining 
(at 1 : 150 to 1 :300 dilution). 
The fusion protein containing residues 1374- 1495 of densin- 180, corresponding to 
the carboxyl-terminus containing the PDZ domain, eluted from the glutathione column as 
95% full-length protein and was dialyzed against PBS, diluted to 1 mg/rnl in PBS and used 
to immunize rabbits (Cocalico Biologicals, Inc). The rabbbit polyclonal antibodies (termed 
CT245) were highly specific for densin- 180 on imunoblots and could be used for 
immunocytochemistry. CT245 serum was used for immunoblots of the PSD fraction (at 
1 :25,000 to 1 : 50,000 dilution) and for imunofluorescent staining (at 1 :2500 to 1 : 5,000 
dilution). 
Immunoblots 
Proteins were separated by SDS-PAGE under reducing conditions, 
electrophoretically transferred to nitrocellulose, and blocked for 2 hours to overnight in 5% 
normal goat serum (NGS) diluted in TTBS (0.2% Tween-20, 10 mM Tris-C1 pH 7.5,O.Z 
M NaCl). After 1 wash in TTBS for 10 minutes, blots were incubated in primary 
antibodies diluted in TTBS / 1% NGS for 3 hours to overnight. Blots were washed three 
times in TTBS, then incubated for 1 hour in alkaline-phosphatase-conjugated goat 
anti-mouse or goat anti-rabbit secondary antibodies (Boehringer Mannheim) diluted in 
TTBS / 1 %NGS. After three 10 minute washes with TTBS, blots were developed 
according to the suppliers instructions. 
Subcellular fractions of rat brain 
Forebrain homogenates, synaptosomes and detergent-extracted PSD fractions were 
prepared from Sprague-Dawley rats exactly as described in (Cho et al., 1992). 
For the membrane extraction experiments, we prepared a crude membrane fraction 
by homogenizing 2 rat forebrains in 20 mls of Buffer A (0.32 M Sucrose / 1 mM sodium 
bicarbonate 1 1 mM MgC12 / 0.5 mM CaClz / 0.1 mM PMSF / 1 mglml leupeptin) at 4' C 
with 6 strokes of a teflodglass homogenizer rotating at 900 rpm. The homogenate was 
cleared by centrifugation at 2500g for 10 minutes, and the supernatant was divided into 10 
separate tubes containing 2 mls each. Membranes were pelleted by centrifugation at 
170,000g for 45 minutes and the crude membrane pellets were resuspended in 2 mls of 
each test extraction buffer by 5 up and down strokes in a teflon glass homogenizer. The 
extractions were incubated at 4 ' ~  for 30 minutes and the membrane residue was pelleted 
by centrifugation at 170,000g for 45 minutes. Supernatants were collected and the pellets 
were resuspended in HKA buffer (10 mM HEPES-KOH pH7.5/140 mM Potassium 
Acetate/l mM MgC12/0.1 mM EGTNO. 1 mM PMSF/5 mg/ml leupeptin). The pellet and 
supernatant fractions were frozen in aliquots at -80" C for use in imunoblots. We used 
the following extraction buffers: 1 M NaCl, 2% CHAPS, 2% Triton X-100, 1 M NaC1/2% 
CHAPS or 1 M NaC1/2% Triton X- 100, all in HICA buffer, or 0.2 M Sodium bicabonate 
buffer, pH 1 1. The presence of densin- 180 in each fraction was assessed by 
imunobloting. Imunoblots with antibody specific for synapsin I were used for 
comparison. Approximately 90% of synapsin was solubilized in 2% CHAPS, 1 M 
NaCl/2% CHAPS, 2% Triton X-100, 1 M NaC1/2% Triton X-100, and pH 11 buffers, but 
only 30% was solubilized in 1 M NaCl. 
Deglycosylation with neurarninidase 
Aliquots of PSD protein (40 pg) were denatured by boiling for 3 minutes in 0.8% 
SDS. N-octyl glucoside was added to a final concentration of 3%. Deglycosylation 
reactions were prepared containing denatured PSD protein (0.8 mg/ml), 0.2 M sodium 
phosphate buffer, pH 7.2, and completeTM Protease inhibitor cocktail (Boehringer 
Mannheim). Forty mU of neurminidase from Arthrobacter ureafasciens (Boehringer 
Mannheim) was added in two aliquots and the reaction proceeded for a total of 24 hours at 
37" C. Control reactions contained no added neurdnidase or included the neurminidase 
inhibitor N-Bromo-succinimide at 10 mM, added in two aliquots with the neurdnidase. 
Fresh protease inhibitors were added twice during the reaction to all tubes. Reactions were 
terminated by boiling in SDSPAGE sample buffer for 3 minutes. Proteins were 
fractionated by SDSlgel electrophoresis, and densin- 180 was detected by imunoblotting. 
Digestion of densin-180 with 0-sialoglycoprotease 
Twenty four pg of non-denatured PSD protein was incubated with 36 pg 0- 
sialoglycoprotease from Pasteurella hemolytica (ACCURATE Chemical & Scientific 
Corporation) in 20 mM sodium phosphate pH 7.4/0.15 M NaC110.2 PMSF in a final 
volume of 60 pl. Protease reactions were incubated at 37" C for 15 minutes, 1 hour, or 3 
hours. Control reactions without added protease were incubated for 3 hours. Reactions 
were terminated by boiling in SDS-PAGE sample buffer for 3 minutes, and proteolytic 
products were fractionated by SDS-PAGE. Fragments of densin- 180 were detected on 
immunoblots probed with either M2 or CT245 anti-densin- 180 antibodies. Control 
immunoblots were probed with anti-PSD-95 (1 : 10,000; Cho et al., 1992) or anti-NMDA 
receptor 2B antibodies (1 :80,000; Kornau et al., 1995). 
Phosphorylation and immunoprecipitation of densin-180 
Phosphorylation reactions contained 24 pg of PSD protein, 50 mM Tris-C1 pH8, 
10 mM MgC12, 0.4 mM EGTA, 10 mM DTT and 10 pglml added calmodulin in a final 
volume of 50 pl. Some reactions also contained 0.6 mM calcium and/or a mixture of 4All  
(0.3 pglpl) and 6E9 (0.4 pglpl) anti-CaMKII inhibiting monoclonal antibodies (Molloy 
and Kennedy, 1991). After a 3 min pre-incubation at 30° C, 3 2 ~ - ~ ~ ~  (10,000 cpdpmol) 
was added to a final concentration of 25pM and the reaction was incubated for 2 rnin at 
30" C. Phosphorylation was terminated by addition of SDS (0.2% final), followed by 
boiling for 3 min. For immunoprecipitation, the phosphorylated protein was brought to a 
final concentation of 0.28 mglml phosphorylated PSD protein in 1X RIPA buffer [ lo  mM 
Tris-C1 pH 7.4 1 1 mM EDTA / 150 mM NaCl / 1 % Triton X- 100 / 1 % sodium 
deoxycholate / 0.1% SDS] in a final volume of 85 p1. The solutions were pre-cleared by 
incubation with 50pg washed protein A-Sepharose beads (Pierce) at 4' C for 2 hours. 
Precleared supernatant was collected and incubated with M2 antibody (10 pl) overnight at 
4" C. This solution was added to 100pg washed Protein A-beads and incubated at 4" C for 
two hours. After 3 washes in 1X RIPA buffer, the beads were boiled for 5 minutes in 
50pl 1.5 X SDS-gel buffer and applied to a 7.5% SDS-PAGE minigel. After 
electrophoresis, the gel was stained with Coomassie R-250, dried, and subjected to 
autoradiography. The amount of densin-180 protein was estimated by comparing the 
Coomassie-stained densin- 180 band with stained bovine serum albumin standards. Bands 
corresponding to densin- 180 were cut from the gel and their radioactivity was determined 
in a Beckman liquid scintillation counter. The stoichiometry of densin phosphorylation 
was estimated at 1 moVmol by calculating a calcium-induced incorporation of 0.21 pmol 
3 2 ~ -  phosphate into 40 ng (.22 pmoles) of densin- 180 protein. 
Isolation of mRNA and Northern blotting 
Total RNA was isolated from rat tissues (frozen in liquid nitrogen and purchased 
from Pel Freeze Biologicals or Harlan Bioproducts) with the acid guanidinium 
thiocyanate-phenol-chloroform-extraction method (Chomczynski and Sacchi, 1987) and 
purified on CsCl gradients. PolyA+ RNA was isolated with the PolyATtract mRNA 
Isolation System (Promega). RNA from different tissues was fractionated on 1 % agarose 
gels and transferred to Zeta-Probe membranes (BIO-RAD) overnight in 20X SSC (3 M 
NaC1/0.3 M Trisodium citrate). RNA transfer was confirmed by staining with methylene 
blue. A cDNA probe corresponding to nucleotides 1950-2400 of the densin-180 cDNA 
was amplified by PCR. The PCR product and human p-actin cDNA (Clontech) were 
radiolabeled by random priming (Random Primed DNA Labeling Kit from USB) to 
specific activities of lo9 and lo7 cpdpg,  respectively. The RNA blots were probed with 
the labeled cDNAs according to the protocol suggested for use with the Zeta-Probe 
membrane. Labeled bands were detected by autoradiography. 
Immunocytochemical labeling of dissociated hippocampal neurons 
Hippocampi from El8 rats were dissociated by trypsinization and cells were plated 
nin-coated coverslips (15 mm in diameter) at a density of approximately 200 per 
mm2. Cultures were plated and maintained in the B27 media described by (Brewer et al., 
1993). After 2 to 4 weeks in vitro, the coverslips were removed from the culture wells and 
placed cell-side up into wells containing ice-cold PBS. After washing briefly in ice-cold 
methanol, cultures were fixed with -20" C methanol for 20 mlnutes, washed once with 
PBS for 15 minutes, then pre-blocked in 5% normal goat semm/0.05% TritonX-1001450 
NaCll20 mM phosphate buffer, pH 7.4 for one hour at 4" C. Next, primary 
antibodies were added in the preblock buffer at appropriate dilutions and incubated 
overnight at 4" C. In addition to the M2 and CT245 anti-densin-1 80 antibodies, the 
following antibodies were also used for immunofluroescent staining: anti-synapsin I rabbit 
antiserum at a 1 : 1000 dilution, affinity-purified anti-PSD-95 rabbit antisemm at 60 pglml 
final concentration (both described in Cho et al., 1992), and 6G9 anti-aCaMKII at 20 
pglml (Erondu and Kennedy, 1985). After 3 washes in the preblock solution, the 
coverslips were incubated in goat anti-mouse or goat anti-rabbit secondary antibodies 
conjugated to FITC or Cy3 fluorophores (diluted 1: 100 in preblock) at RT. Coverslips 
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were washed once in the preblock buffer for 15 min, twice with PBS for 15 min, 
post-fixed 5 min with 2% paraformaldehye, washed twice with PBS for 10 min, and twice 
with 0.1 M sodium bicarbonate pH 9.2 for 5 min. Coverslips were then mounted on slides 
in 80% glycerol / 4 m g / d  p-phenylenediamine 10.1 M sodium bicarbonate buffer, pH9.2, 
left at RT for 2 hours, then either viewed immediately, or stored at -20" C for no longer 
than one week. Cultures were viewed in a fluorescence laser-scanning confocal 
microscope (Zeiss LSM3 10). A 63X oil immersion objective was used at electronic zoom 
factors of 1 or 2. Images were scanned at 64 sec. Fluorescein was excited at 488nm and 
Cy3 at 543nm. Images were collected through filters appropriate for the two fluorophores. 
The contrast and brightness setting were optimized to spread the data over the 8-bit range. 
Contrast settings were 360-410 and brightness settings were 6000-6800. Double images 
were colorized and aligned in Adobe Photoshop without adjusting the original data. Final 
images were printed at 300 dpi resolution on a Kodak XLS 8300 Printer. 
The concentrations of the antibodies were estimated by comparison to IgG 
standards on SDS-PAGE gels after staining with Coomassie Blue R-250. The M2 mouse 
IgG was -0.3 mg/ml and the CT245 rabbit IgG was -5 mg/ml. Preabsorption of 
anti-densin- 180 antibodies with antigen at a 1 :3 molar ratio entirely blocked staining at the 
contrast and brightness settings above. 
RESULTS 
PCR cloning based on tryptic peptide sequences 
The purification of densin- 180 (previously termed PSDup- 180) was described 
previously Moon et al., 1994. Briefly, the crude PSD fraction was isolated from rat 
forebrain, extracted with 1% NOG, deglycosylated and applied to 6% preparative SDS 
polyacrylamide gels. Densin- 180 was then electroeluted and trypsinized as described 
under Materials and Methods. Seven tryptic peptides were purified sufficiently for 
automated sequencing. A search of the GenBank data base performed with the BLAST 
network service revealed that three of these peptide sequences are not homologous to any 
known protein. 
Initial attempts to select cDNA clones by screening several libraries with 
radiolabeled "guessmer" oligonucleotides based on the sequence of peptide 1 proved 
unsuccessful. Therefore, we used a PCR-based approach similar to that of (Saiki et al., 
1988). Several sets of degenerate 29 base sense and antisense oligonucleotide primers 
were designed based on the sequences of the three peptides (Figure 1A). The neutral base 
inosine was included at 8 or fewer positions to reduce primer degeneracy to no more than 
32-fold. All possible combinations of sense and antisense primers were used for PCR 
amplification of rat brain cDNA. Out of all possible primer combinations, only the 
(1Sense + 3Antisense) reaction produced a 1.2 kb PCR product that was absent in control 
reactions containing only the primers (Figure 1C). This product was cloned and 
sequenced. The strategy for obtaining and analyzing this clone is diagrammed in Figure 
1B. The sequence immediately 3' downstream of the lSense primer encoded the amino 
acids Val-Arg, matching the corresponding amino acid sequence of peptide 1. In addition, 
the complementary sequence immediately 3' downstream of the 3Antisense primer 
no acids Ser-Gln-Ser, corresponding to the amino acid sequence of peptide 
3. We found that the 1.2 kb fragment could be amplified from rat brain cDNA, but not 
from cDNA made from other tissues (data not shown), suggesting that the encoded protein 
is brain specific. Partial sequences of the PCR product were compared to the database and 
found to encode a novel protein. 
Cloning and sequencing of full length densin-180 cDNAs 
The PCR product was labeled by random priming and used to screen a Lambda 
Zap I1 rat brain cDNA library (kindly provided by Dr. Terry Snutch). Five independent 
positive cDNA clones spanning 6.8 kb were aligned by restriction mapping and partial 
sequencing (Figure ID). The entire 5.2 kb cDNA clone 1.1 was sequenced; we found that 
it contains the complete densin- 180 open reading frame. It includes an initiation codon at 
position 186 preceded by a stop codon at 177, which fits the consensus for translation 
initiation sites (Kozak, 1989). There is also a purine-rich Shine-Dalgamo ribosome 
binding consensus motif beginning about 10 nucleotides upstream of the initiation codon 
(Shine and Dalgamo, 1974). This initiation codon is followed by a single 4485 bp open 
reading frame encoding a 1495 residue protein with a molecular weight of 167,499. The 
complete nucleotide sequence and the amino acid sequence that it encodes is shown in 
Figure 2. All three of the original tryptic peptide sequences (Figure 1) are present in the 
amino acid sequence. Sequences 1 and 3 match exactly and sequence 2 has one mismatch 
(Arg at position 8 corresponds to a Trp in densin-180). This mismatch most likely results 
from an ambiguous call during the peptide sequencing and explains the absence of specific 
PCR products from the 1Sense/2Antisense and 2Sense/3Antisense primer combinations. 
The message encoding densin- 180 may be alternatively spliced. Partial sequencing 
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of two more of the cDNAs (2.1 and 3.1; Fig. ID) revealed possible splice variants. A 76 
nucleotide sequence is missing at the 5' end of clone 2.1 when compared to clone 1.1 
(underlined in Figure 2). This sequence spans nucleotides 1 1 1 to 186 of the densin- 180 
sequence and includes the ribosome binding site and the adenosine of the ATG initiation 
codon. Clone 3.1 contains a 249 bp deletion between nucleotides 163 1 and 1881 of clone 
1.1 that does not shift the reading frarne (underlined in Figure 2). 
Domain structure of densin-180 
A search of the GenBank data base performed with the BLAST network service 
through the National Center for Biotechnology Information revealed significant homology 
in the N-terminus of densin- 180 with the superfamily of leucine-rich repeat (LRR) 
containing proteins. Alignment of the 15 contiguous LRRs in densin- 180 reveals a 
repeating 23-residue consensus sequence (Figure 3A) that fits the general consensus 
defined for LRRs from a variety of transmembrane and secreted proteins, including 
adhesion molecules (for review of LRR-containing proteins, see (Kobe and Deisenhofer, 
1994 and Kobe and Deisenhofer, 1995b). LRRs vary from 20 to 29 residues in length, 
with 24 residues most common. Clusters of cysteine residues are found immediately 
flanking the LRRs. At the amino terminus, three cysteine residues are found between 
amino acids 19 and 37, and on the carboxyl side six cysteine residues are found between 
residues 486 and 546. Cysteine-rich domains typically flank the LRRs of adhesion 
molecules, but the densin-1 80 cysteine clusters seem to be of a different type since they do 
not match the consensus described in (Kobe and Deisenhofer, 1993). 
Amino acids 825-9 15 define a region rich in serine, threonine and proline residues 
similar to repeats found in mucin. Mucin-like repeats are thought to serve as sites of 
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attachment of 0-linked sugars in mucin and many other proteins, including GPIbcl (for 
review, see Strous and Dekker, 1992 and Van Klinken et al., 1995). 
The BLAST search identified a clear PDZ domain at the carboxyl-terminus, 
spanning residues 1405 to 1492. (Figure 3B). The PDZ motif was first defined in 
PSD-95, another PSD protein identified in our laboratory. The motif is present in a variety 
of other proteins associated with intracellular junctions including the Drosophila discs-large 
(dlg) protein (Woods and Bryant, 1991) and the human tight junction protein, ZO- 1 (Itoh 
et al., 1993). 
Initial analysis of the densin- 180 sequence failed to reveal a hydrophobic signal 
sequence expected in a transmembrane protein. However, the SIGCLEAVE program 
identified an embedded signal sequence spanning amino acids 28-40 with cleavage at 
residue 41 and a score of 3.6. The SIGCLEAVE program uses the von Heijne method to 
locate signal sequences and is 95% accurate with a score of 3.5 or higher. Using the 
method of Kyte and Doolittle to predict regions of high hydrophobicity in the sequence, we 
have assigned a transmembrane domain from residues 1223 to 1246, placing the PDZ 
domain on the cytosolic side. The 24-residue putative transmembrane domain is atypical 
because it contains nine charged and polar amino acids. Helical wheel projections of this 
region using the HELICALWHEEL program reveal an amphipathic helix-like structure 
with one face of the alpha-helical surface containing exclusively hydrophobic residues and 
the rest of the surface containing a mixture of hydrophobic, charged and polar residues 
(data not shown). 
Analysis of the sequence with the MOTIFS program identified an Arg-Gly-Asp 
(RGD) tripeptide sequence between the LRR domain and the cysteine rich repeats (amino 
83 
acids 437-439 in Figure 2). The RGD tripeptide was originally identified as a sequence in 
fibronectin that mediates cell attachment. RGD sequences from fibronectin and a number 
of other proteins have been found mediate adhesion via binding to integrins (for review, 
see DtSouza et al., 1991). Finally, we identified two consensus sequences that are potential 
sites of phosphorylation by CaM Kinase I1 (Figure 2; see below). 
The arrangement of domains in densin- 180 is similar to that of the family of LRR- 
containing glycoproteins, although there is little significant sequence homology with any of 
them. One of the most well-characterized of the LRR-containing glycoproteins is the 
platelet adhesion molecule GPIba (Lopez et al., 1987). Both densin- 180 and GPIba 
contain leucine-rich repeats flanked by cysteine rich domains and mucin homology 
domains in the putative extracellular portion of the proteins (Figure 3C). The PDZ domain 
of densin- 180, which likely represents a protein binding site (Kornau et al., 1995 and Kim 
et al., 1995), is in a position analogous to the cytosolic actin binding protein (ABP)-binding 
domain of GPIba. GPIbcl is part of a protein complex that mediates binding of von 
Willebrand factor via its LRR domain and flanking cysteine-rich domain. The binding 
induces adhesion of platelets to blood vessels (for review, see Williams et al., 1995). The 
C-terminus of GPIba has been shown to interact with actin binding protein (ABP) to 
mediate association with the cytoskeleton (Andrews and Fox, 1992). 
Densin-180 associates with the particulate fraction 
The domain structure of densin- 180 places it in the family of LRR-containing 
glycoproteins which span the membrane, yet the putative transmembrane domain contains 
several charged and polar amino acids. To test whether densin- 180 associates with 
membrane fractions, we extracted crude membranes from rat forebrain with detergent 
and/or salt. Imunoblots of the soluble and particulate fractions were prepared and probed 
with specific mouse polyclonal antibodies raised against recombinant densin- 180 protein. 
These antibodies react strongly with a 180 kDa band that migrates at the position of the 
densin-180 protein on an SDS gel (Fig. 4). Densin-180 is not solubilized by extraction 
with 2% Triton X-100, or 2% CHAPS, conditions that solubilize many membrane 
proteins, but do not solubilize proteins tightly bound to the PSD fraction. When the 
membranes were extracted with 1 M NaCl to disrupt protein interactions densin-180 also 
remained in the pellet fraction. However, when the membranes were extracted with a 
combination of 1 M NaCl and 2% Triton X-100 or of 1 M NaCl and 2% CHAPS, 
approximately half of the densin- 180 was solubilized. Taken together, the solubility profile 
is consistent with anchoring of densin- 180 in the membrane fraction by a combination of 
lipid and protein interactions. 
Extraction with sodium bicarbonate buffer, pH 11, also solubilized about half of the 
densin- 180. It is generally assumed that high pH buffers extract mainly peripheral 
membrane proteins, yet its sequence and biochemical characteristics (see below) suggest 
that densin- 180 is a transmembrane protein. This unusual extraction profile could reflect 
the atypical sequence of densin- 180's putative transmembrane domain. The ability of the 
two positive (R, K) and two negative (D, E) residues in this domain to form salt bridges 
with other transmembrane proteins may explain the sensitivity of densin-1 80 to extraction 
in pH 1 1 buffers. 
Densin-180 is a sialoglycoprotein 
The predicted amino acid sequence of densin- 180 implies a molecular weight of 
167 kDa, but the densin- 180 protein migrates at an apparent molecular weight of 188 kDa 
on a 7.5% SDS polyacrylamide gel. One explanation for this discrepancy could be that it is 
glycosylated, as would be expected for a transmembrane protein. We tested whether 
densin- 180 is glycosylated by treating the PSD fraction with various glycosidases. Only 
very slight shifts in the mobility of densin-180 were observed after treatment with 
N-glycosidase F or 0-glycosidase. However, a shift in its apparent molecular weight from 
approximately 188 kDa to 148 kDa was evident after treatment with neuraminidase from 
Arthrobacter ureafasciens (Figure 5A). The shift in molecular weight was due to the 
neuraminidase activity and not to contaminating protease activity because addition of a 
specific inhibitor of the Arthrobacter ureafasciens neuraminidase, 10 mM N- 
bromosuccinimide, inhibited the shift in molecular weight. Thus, the densin- 180 protein is 
heavily glycosylated with sialic acid residues. 
An 0-sialoglycoprotein endoprotease has recently been identified from Pastearella 
haemolytica that specifically cleaves proteins containing mucin-like 0-linked glycans 
(Abdullah et al., 1992 and reviewed in Mellors and Sutherland, 1994). Substrates that have 
been identified contain 15 or more closely spaced 0-linked glycosylation sites along the 
protein backbone (Norgard et al., 1993). These substrates include GPIba (Yeo and 
Sutherland, 1993), cranin (Smalheiser and Kim, 1995), glycophorin A (Abdullah et al., 
1992), CD34 and CD43 (Sutherland et al., 1992), and epiglycanin (Kemperman et al., 
1994). To test the sensitivity of densin- 180 to this protease, an aliquot of the 
non-denatured PSD fraction was incubated with protease for varying times (Fig. 5B and 
5C). PMSF was included in all incubations to inhibit serine proteases. The digested PSD 
proteins were fractionated by SDS-PAGE, transferred to nitrocellulose, and incubated with 
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antibodies M2 and CT245, which are specific for the extracellular and intracellular portions 
of densin-180, respectively. After 3 hours of incubation with protease, complete loss of 
the 185 kDa densin-180 band was evident in both imunoblots. The pattern of proteolysis 
detected with each antibody was consistent with initial proteolysis at a site near the mucin 
homology domain of densin- 180, producing extracellular fragments with approximate 
molecular weights of 140 and 120 kDa detected by the M2 antibody. The largest major 
breakdown product detected with the CT245 antibody had a molecular weight of 
approximately 65 kDa, corresponding to a site of initial proteolysis in the mucin homology 
domain of densin- 180. The CT245 antibody also detects a 2 1 kDa protease-resistant 
fragment even after 3 hour incubations (Figure 5B), suggesting that the C-terminal region 
of densin-180 may be inaccessible to the protease because of tight interactions with other 
PSD proteins. Epitopes of other sialoglycoproteins have been shown to resist proteolysis 
(see Mellors and Sutherland, 1994). Control blots of PSD digests detected no 
0-sialoglycoprotein sensitivity for either NR2B or PSD-95, even after 3 hours incubations 
(data not shown). 
Densin-180 is phosphorylated by CaM Kinase I1 
CaM Kinase I1 (CaMKII) is highly concentrated in the PSD as determined by both 
biochemical and imunocytochemical experiments (Kennedy et al., 1983 and Kennedy et 
a]., 1990) and can be activated in vitro in the PSD fraction. We labeled substrates of 
CaMKII in the PSD fraction by carrying out a phosphorylation reaction for two minutes at 
30" C in the presence of calcium, calmodulin, and 3 2 ~ - ~ ~ ~ .  After phosphorylation, 
densin-180 was immunoprecipitated from the PSD fraction. Figure 6 shows an 
autoradiogram of the immunoprecipitates. Phosphorylation was stimulated by calcium and 
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reached a stoichiometry of approximately one picomole phosphate per picomole protein, 
estimated as described under Materials and Methods. The reaction was inhibited 
approximately 90% by addition of two antibodies against CaMKII that have been shown to 
inhibit kinase activity (Fig. 6, lane 3; Molloy and Kennedy, 1991). Thus, densin- 180 is 
specifically phosphorylated by endogenous CaMKII in the PSD fraction. This 
phosphorylation and the extensive glycosylation of densin- 180 are consistent with the 
transmembrane orientation proposed in Fig. 3C. 
Densin-180 mRNA is detected only in brain 
Northern blots prepared with PolyA+ RNA from several tissues of 10 week old 
rats and from forebrain of 5 week old rats were probed for messages encoding densin- 180. 
A single 7.4 kb message was detected in forebrain, and faintly in cerebellum (Figure 7A). 
There was no detectable densin- 180 mRNA in any of the other tissues. Densin- 180 
A was expressed at a higher level in the forebrain of 5 week old than of 10 week old 
rats (leftmost lane of Fig. 7A), suggesting age-dependent regulation of mRNA expression. 
Densin-180 is highly enriched in PSD fractions 
One criterion for specificity of the association of a protein with the PSD fraction is 
its enrichment in the PSD fraction, compared to other subcellular fractions. This 
enrichment has been shown for CaMKII (Kennedy et al., 1983), PSD-95 (Cho et al., 
1992), and the 2B subunit of the NMDA receptor (Moon et al., 1994). We prepared 
imunoblots of rat brain homogenates, synaptosomes, and three different PSD fractions 
extracted with successively harsher detergent (Figure 7B). The 180 kDa densin- 180 band 
is highly enriched in synaptosomes as compared to crude homogenate and is also enriched 
in all of the detergent-extracted PSD fractions compared to synaptosomes. Densin-1 80 
remained associated with the PSD fraction even after extraction with N-lauroyl sarcosinate 
and therefore can be considered a "core" PSD protein. 
Densin-180 is located at synapses in dissociated hippocampal neurons 
Antibodies to densin- 180 were used for imunocytochemical staining of 
dissociated rat brain hippocampal cell cultures. Hippocampal neurons plated at E 18 were 
grown in culture for two to four weeks (Brewer et al., 1993). Cells were stained as 
described under Materials and Methods with antibodies against densin- 180, synapsin I, 
PSD-95 and the a subunit of CaMKII. Confocal imaging revealed that the staining for 
densin- 180 was membrane-associated and punctate along dendrites with little cytoplasmic 
staining above background (Figure 8). Staining of the axon initial segment was also 
frequently observed (Figure 8B). The pattern of staining was identical for the M2 and 
CT245 antibodies (Appendix I). Staining with both antibodies was completely blocked by 
overnight preabsorption with their antigens (Appendix I). 
We used mouse and rabbit anti-densin- 180 antibodies to double-label with 
antibodies against other synaptic markers. Staining for synapsin I overlaps significantly 
with densin- 180 staining (Figure 8A) and thus confirms that densin- 180 is a synaptic 
protein. Synapsin I associates with synaptic vesicles in the presynaptic terminals of 
neurons. At higher magnification, it is evident that the synapsin I is present in a larger area 
than densin- 180, extending away from the dendrite. This structure likely corresponds to 
the presynaptic terminal (Figure $A, inset). 
Double-labeling with antibodies to densin- 180 and PSD-95 revealed a more strict 
correlation of the extent of staining (Figure 8B, inset). Finally, double-labeling with 
densin- 180 and the a subunit of CaMKII resulted in correlated punctate staining along 
dendrites. However, densin- 180 is not found in as large quantities in the cytoplasm of 
dendritic shafts or cell bodies as is CaMKII (Fig. 8C). Images of this staining at high 
magnification, reveal that densin-180 is located along dendrites at what appear to be spines 
(inset, Figure 8C). The high degree of colocalization of densin-180 with the postsynaptic 
density markers PSD-95 and CaMKU provides additional evidence for localization of 
densin- 180 at the synaptic junction. We have not yet determined whether densin- 180 is 
presynaptic, postsynaptic, or both. 
DISCUSSION 
We have employed direct sequencing of protein bands from the PSD fraction, 
followed by molecular cloning, to characterize proteins associated with the PSD because 
the highly insoluble nature of the PSD renders traditional biochemical purification schemes 
inadequate. In the study reported here, the strategy was complicated by the existence of 
more than one comigrating protein in the region of the densin- 180 band (Moon et al., 
1994). To circumvent this potential problem, we used a PCR strategy that allowed us to 
confirm the presence of DNA encoding at least two of our peptide sequences in PCR 
clones before screening cDNA libraries, reducing the risk of cloning a minor contaminant 
of the PSD fraction. This strategy enabled us to clone densin- 180, a novel LRR-containing 
molecule expressed only in the brain. The domain structure of densin-180 places it in the 
leucine-rich repeat containing family of proteins and suggests it is an adhesion molecule. 
Two cDNA variants were characterized by restriction mapping and partial sequence 
analysis, in addition to the one described in detail here. One of these lacks the 
ribosome-binding domain of the 5'-untranslated region, suggesting that alternative splicing 
might regulate the expression of densin- 180. The second variant lacks the 
carboxy-flanking cysteine rich domain that might be important in ligand binding and is 
found in a most LRR glycoproteins. 
The LRR-containing family of proteins has a wide range of functions including cell 
adhesion and signal transduction. The crystal structure of one member of the family, 
porcine ribonuclease inhibitor protein (RI) has been reported. The structure was 
determined for the protein alone and bound to ribonucleaseA (Kobe and Deisenhofer, 1993 
and Kobe and Deisenhofer, 1995a). The stsuctures reveal the molecular basis for the tight 
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association of RI with the ribonuclease and serve as a model for the high affinity 
protein-binding by LRRs from other proteins. 
The largest group of LRR-containing proteins serve as adhesion molecules. 
Proteins in this group often contain cysteine rich domains flanking the LRR on the amino- 
and carboxyl-terminal sides. Many proteins involved in Drosophila development are 
LRR-containing proteins (see Hortsch and Goodman, 199 1, for review). Drosophila 
LRRs that mediate homotypic adhesion include chaoptin, important for eye development 
(Krantz and Zipursky, 1990), connectin, involved in axon pathfinding and formation of 
neuromuscular connections (Nose et al., 1992, and Meadows et al., 1994), and toll, which 
is required for formation of dorsal/ventral polarity in the embryo (Hashimoto et al., 1988) 
and (Keith and Gay, 1990). In mammalian platelets, all four members of the GPIb 
complex contain LRRs, but only GPIBa binds directly to von Willebrand factor inducing 
adhesion of platelets to blood vessels. In the mammalian brain, densin-1 80 is a new 
member of a growing family of LRR glycoproteins that include trk (Martin-Zmca et al., 
1989), trkB (Klein et al., 1989); (Schneider and Schweiger, 199 I), oligodendrocyte myelin 
glycoprotein (Mikol et al., 1990) and NLRR-3 (Taniguchi et al., 1996). 
Densin-180 contains an RGD cell attachment motif between the last LRR md the 
C-terminal cysteine rich domain (Fig. 2). NLRR-3 cloned from mouse brain is an LRR- 
glycoprotein that contains an RGD sequence in the predicted a-helical region of the eighth 
LRR, RGD motifs in extracellular matrix molecules have been shown to mediate 
intracellular responses by binding to integrins (D'Souza et al., 1991). There is evidence for 
integrins at the synapse since RGD peptides block long-term potentiation (Xiao et al., 
199 1) and a 55 kDa RGD-binding protein purified from synaptic membranes cross-reacts 
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with anti-a, p, integrin antibodies (Bahr and Lynch, 1992). Thus, densin- 180 and 
NLRR-3 may interact with integrins. 
We have identified densin-1 80 as a sialomucin by two criteria; the large shift in its 
apparent molecular weight on SDS-gels after neuraminidase treatment (Fig. 5A), and its 
sensitivity to proteolysis by 0-sialoglycoprotein endopeptidase (Fig. 5B and 5C). The 
0-sialoglycoprotein endopeptidase is highly specific for sialomucins and is used as a 
diagnostic tool (Mellors and Sutherland, 1994). GPIba (Yeo and Sutherland, 1993) and 
cranin (Smalheiser and Kim, 1995) are also sensitive to this protease. Cranin has recently 
been identified (Smalheiser and Kim, 1995) as the brain form of alpha-dystroglycan, a 
putative agrin receptor that mediates acetylcholine receptor clustering at the neuromuscular 
junction (Fallon and Hall, 1994). 
The 0-glycosylated domain in sialomucins forms an extended filamentous 
conformation, 2.5 Angtroms per residue in length (see Strous and Dekker, 1992). The 
extended structure is surrounded by a cloud of negative charges associated with the sialic 
acid residues (Jentoft, 1990). In some cases, the negative charges play a protective role by 
repelling adhesion molecules on other cells. In other cases, 0-linked sialic acids are 
required for specific binding to lectin domains of selectins (Cummings and Smith, 1992). 
Finally, the filamentous domain can act as a stiff rod to extend a ligand binding domain for 
interaction with other cells or with the extracellular matrix (reviewed in van der Menve and 
Barclay, 1994). 
The solubility properties of densin-180 are unusual and are reminiscent of those of 
a-dystroglycan, which has been reported as a transmembrane protein, a peripheral protein, 
and a membrane-associated extracellular protein (Ervasti and Campbell, 1993 and Ma et 
al., 1993). Densin-180 is most effectively solubilized either by a combination of non-ionic 
detergent and high salt or by pH 1 l buffers. A portion of densin- 1 80 is extracellular as 
evidenced by its glycosylation. We have identified a possible membrane spanning domain 
near the carboxyl terminus followed by a PDZ protein-interaction domain (Fig. 3B). It 
seems most likely that the PDZ domain is located in the cytosol where it would associate 
with intracellula proteins. However, a definitive model of densin- 180's membrane 
orientation remains to be established. 
The cytoplasmic domains of transmembrane proteins often have important 
functions in signal transduction across the membrane. Examples in the LRR family are 
toll protein, which contains an interleukin- 1-like cytoplasmic domain (Hashimoto et al., 
1988) and gp150, which contains a receptor protein tyrosine phosphatase 
(PTPase)-binding domain that is phospholylated on a tyrosine residue in vitro (Tian and 
Zinn, 1994). In addition, the ABP binding domain at the C-terminus of GPIba is likely to 
mediate cytoskeletal rearrangement in response to ligand binding (Andrews and Fox, 
1992). Densin-180 contains a PDZ domain at its carboxyl terminus that may participate in 
binding to cytoplasmic elements. PDZ domains have been identified as protein-binding 
motifs. For example, the second PDZ domain (PDZ2) of PSD-95 interacts with a short 
sequence SDV*, termed tSXV, at the extreme C-terminus of the 2B subunit of the 
NMDA-type glutamate receptor and this interaction has been proposed to anchor NR2B in 
the PSD (Kornau et al., 1995). Additionally, the PDZ2 domain from PSD-95 binds to 
tSXV motifs in a subset of potassium channels (Kim et al., 1995), and the PDZ domains 
of syntrophin and nNOS (Brenman et al., 1996). PDZ domains thus appear to play a role 
in the association of proteins in signal transduction complexes, in particular at cellular 
junctions. The identification of a 2 1 kDa protease-resistant C-terminal fragment of 
densin- 180 after a 3 hour digestion of densin in the PSD, suggests that this putative 
cytoplasmic domain may be tightly embedded in the PSD via the PDZ domain. Similar 
protease-resistant epitopes have been observed in 0-sialoglycoprotease digestions of CD34 
(Sutherland et al., 1992). It is notable that there is a consensus CaMKII phosphorylation 
no acids from the densin- 180 C-terminus, immediately following the 
PDZ domain (Fig. 2). It is possible that the phosphorylation of densin-180 by CaMKII 
(Fig. 6) regulates the association of densin-180 with binding partners in the PSD. 
Immunocytochemical studies suggest a localization of densin- 180 at the synaptic 
membrane (Fig. 8). Double-imunofluorescence labeling with densin- 180 and synapsin 
I, a synaptic vesicle marker, reveals clear co-localization of the two molecules. However, 
at higher magnification a slight shift of some of the synapsin I staining away from the 
dendrite relative to the densin-180 staining is apparent (Fig. 8A), suggesting that 
Densin- 180 immunoreactivity is closely associated with the junctional membrane. We 
have not yet determined whether densin-1 80 is concentrated on the postsynaptic side of the 
junction. Double-imunofluorescence labeling of densin- 180 and PSD-95, a 
PSD-marker, reveals that the two molecules precisely colocalize in mature cultured 
neurons, within the limit of resolution of the laser-scanning confocal microscopy. 
Interestingly, an exception to the co-localization of densin- 180 with PSD-95 is at the axon 
initial segment. Anti-PSD-95 does not label the initial segment, while densin- 180 labels 
this structure strongly (Fig. 8B). Densin-180 partially colocalizes with CaMKII at what 
appear to be spines, but does not colocalize with CaMKII in the cytoplasm of dendrites and 
cell bodies. 
Densin- 180 and the platelet surface protein GPIba contain an assembly of similar 
domains in their structure that suggests they may function in similar way. GPIba 
mediates adhesion of platelets to von Willebrand factor (vWF) that is exposed in the 
extracellular matrix of injured blood vessels. This adhesion has a very rapid rate of bond 
formation and a high resistance to tensile stress, functioning to immobilize platelets on 
vWF in the presence of high shear forces. However, this adhesion is also highly reversible 
and is not sufficient to permanently immobilize platelets to the blood vessel wall. Rather, 
the GPIba association with vWF facilitates binding of aIlbP3 integrins on the platelet 
surface to the RGD domain of vWF. We hypothesize that a similar type of adhesion may 
be mediated by densin- 180 at the synapse. Possibly, the RGD sequence in densin- 180 
binds directly to integrins on the surface of apposing synaptic terminals, eliminating the 
requirement for large extracellular matrix molecules in the synaptic cleft. 
In conclusion, the location of densin- 180 at the synapse and the similarity of its 
domain structure to those of adhesion molecules imply a role for densin- 180 in the 
adhesion of pre and postsynaptic membranes. Its domain structure suggests several 
hypotheses. First, the sialomucin region of densin-180 may form an extended 
conformation across the synaptic cleft to present the LRR-containing ligand binding 
domain to the apposing synaptic membrane. Second, the presence of an RGD sequence in 
this domain suggests that a synaptic membrane ligand may be an integrin-like protein. 
Third, the 0-linked sugars could also mediate selective adhesion through selectin-like 
molecules. Together, these extracellular motifs have the potential for the tight yet flexible 
adhesion that may be important in synapse formation, maintenance and plasticity. Fourth, 
on the cytoplasmic face, densin- 180 may participate in assembly and maintenance of the 
PSD structure through its PDZ domain. Finally, densin- 180 function may be regulated by 
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CaMKII-mediated signal transduction. We are presently testing these hypotheses. 
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FIGURE LEGENDS 
Figure 1. Tryptic peptide sequences and PCR cloning of densin- 180. 
A. Arnino acid sequences of three densin-180 tryptic peptides were used to design sense 
(S) and antisense (A) degenerate 29mer oligonucleotide primers [A, adenosine; C, 
cytosine; G, gumosine; I, inosine; T, thymidine; degenerate nucleotide positions are 
enclosed in parentheses]. The ten amino acids used to design the sense (right pointing 
arrows) and antisense (left pointing arrows) are indicated above and below the peptide 
sequences respectively. B. Densin- 180 PCR cloning strategy. Combinations of sense and 
antisense primers (arrows) were used for PCR amplification from rat forebrain cDNA. 
PCR products (represented by a gray box) were cloned into a vector and sequences of the 
insert determined by sequencing from the vector's MI3 and T7 primer sites (bold arrows). 
C. PCR reactions were fractionated on a 1.2% agarose gel and the DNA visualized by 
ethidium bromide staining. PCR product size was estimated by comparing with DNA 
molecular weight markers. The IS + 3A primer combination produced a 1.2 kb PCR 
product (bold arrow) that is absent in the control 1s  or 3A reactions. D. Restriction map 
and sequencing strategy for cDNA clones encoding densin- 180. Clone 1.1 was sequenced 
in it's entirety and the coding region (open box ), the region of hybridization with the PCR 
product (gray box) and the 5' and 3' noncoding regions (horizontal lines.) are indicated on 
the restriction map (map units are in base pairs). The locations of cDNA clones 
determined by restriction mapping and sequencing are shown below. The extent and 
directionality of overlapping cDNA sequences are depicted as arrows for each cDNA 
clone. Rensin- 180 cDNA clone 2.1 lacks nucleotides 1 1 1 to 186 of the densin 180 
sequence (broken line) containing the ribosome binding site and part of the initiation codon. 
Clone 3.1 lacks a 249 base pair sequence spanning nucleotides 1632 to 1880 of the 
densin- 180 sequence (broken line). 
Figure 2. Densin- 180 cDNA sequence and protein translation. The DNA sequence of 
clone 1.1 determined by sequencing both strands is shown with the protein translation 
below. This sequence will be submitted to GenBank. DNA sequences that are missing 
from clones 2.1 and 3.1 are underlined. The protein sequences of tryptic peptides 1, 2, 
and 3 are also underlined. Potential N-linked glycosylation sites, CaMKII phosphorylation 
sites (bold) and RGD cell attatchment motif are shown as boxed residues. The potential 
transmembrane domain is underlined (gray bar) and the sixteen leucine-rich repeats are 
contained in amino acids 53-420. The amino- and carboxy-flanking cysteine rich domains 
span amino acids 19-37 and 486-546, respectively. The mucin homology domain (amino 
acids 825-9 15) and the PDZ domain (amino acids 1405-1492) are found in the sequence. 
Figure 3. Domain structure of densin- 180. A. Alignment of the fifteen densin- 180 
leucine-rich repeats reveal a 23 residue consensus shown below. Corresponding amino 
acid numbers of densin-1 80 are indicated to the left of the first repeat and to the right of the 
sixteenth repeat. B. Identification of a PDZ domain in densin- 180. Alignment of amino 
acids 1400 to 1493 of densin- 180 with PDZ domains from four other proteins (three PDZ 
domains from PSD95, (Cho et al., 1992); three from Drosophila discs-large, dlg (Woods 
aand Bryant, 1991); three from the human zona occludens protein, ZO-1, (Itoh et al., 
1993); and one from neuronal nitric oxide synthase, nNOS (Bredt et al., 1991). C. The 
domain structure of densin- 180 compared to the LRR-containing glycoprotein, GPIba. 
The leucine-rich repeats (fifteen in densin- 180 and seven in GPIba, wavy boxes), with N- 
terminal and C-te nal cysteine rich flanking regions (stippled boxes), and mucin-like 
domains (boxes with diagonal lines) are indicated for both proteins. Potential 
transmembrane domains are depicted as black bones. The ABP binding protein domain of 
GPIbcx and the PDZ domain of densin-180 at the C-terminal regions of the proteins are 
represented by gray boxes. The position of the RGD sequence is also shown. Scale bar 
represents 150 amino acids. 
Figure 4. Solubility of densin-180 in brain membrane fractions. Crude membrane 
fractions were isolated from rat brain and extracted with indicated buffers. Tmunoblots 
were prepared with the pellet (P) and supernatant (S) fractions from a 170,000g 
centrifugation after extraction with 1 M NaC1,2% CHAPS,l M NaCl + 2% CHAPS, 2% 
Triton, 1 M NaCl + 2% Triton, or 0.2 M Sodium Bicarbonate pH 11, for 1 hour at ~ O C .  
Figure 5. Densin- 180 is a mucin-like sialoglycoprotein. A. Densin- 180 is heavily 
glycosylated with sialic acid. Twenty micrograms of denatured PSD fraction were used 
for anti-densin- 180 imunoblots after incubating overnight incubation 37OC under the 
following conditions: control reaction with no added neuraminidase (Lane I), with added 
neuraminidase (Lane 2), and with added neuraminidase plus 10 mM 
N-Bromo-succinimide (Lane 3). The 188 kDa undigested (upper arrow) and 148 D a  
digested (lower arrow) densin- 180 protein bands are shown. The 205, 1 18 and 87 kDa 
molecular weight markers are shown at left. B and C. Proteolysis of densin- 180. 
Twenty-four micrograms of non-denatured PSD fraction was incubated with 0.4 mg/ml 
final volume of 0-sialoglycoprotein endoprotease (Accurate Chemical and Scientific 
Corporation). All incubations were carried out in the presence of 0.2 mM PMSF to inhibit 
endogenous proteases in the PSD fraction. Control reactions with no protease added were 
incubated for 3 hours at 37O~. All reactions were incubated at 37OC for 15 minutes (Ism), 
1 hour ( Ih)  and 3 hours (34. Reactions were terminated by adding gel sample buffer and 
boiling for 3 minutes. I unoblots were prepared with these samples. B. Imunoblot 
was probed with the CT245 antibody, a rabbit polyclonal serum that reacts with epitopes in 
part of the potential cytoplasmic domain spanning residues 1374- 1495 of densin- 180. The 
CT245 anitbody detects the undigested 188 kDa densin- 180 protein band (large black 
arrow) and a complex pattern of proteolytic fragments (gray arrows) of densin- 180. 
These proteolytic fragments include major bands at approximately 70 kDa, 45 kDa 
(doublet), 40 kDa (doublet), 30 kDa and 20 kDa. The 20 kDa band (large gray arrow) is 
resistant to proteolysis after 3 hours at 37O~. C. Immunoblots were prepared with M2 
anti-densin- 180, a mouse polyclonal ascites that reacts with epitopes contained in amino 
acids 466-958 of densin- 180's putative extracellular domain. The undigested 188 kDa 
densin- 180 protein band (large black arrow) and the 140 and 120 kDa proteolytic 
fragments (gray arrows) of densin-180 detected by the M2 antibody are identified. For 
both B and C, size standards appear at the side with open arrowheads indicating the gel 
origin (top) and dye front (bottom). 
Figure 6. Densin-180 is phosphorylated by endogenous aCaMKII in the PSD fraction. 
Control reactions were set up containing 24pg of PSD fraction and 50 mM Tris8, 10 
EGTA, 10 mM DTT and l0pg/rnl added calmodulin (Lane 1). 
Additional components added to reactions were as follows: 0.6 mM calcium (Lane 2 and 
3) and 4A1l (0.3 pglpl) and 6E9 (0.4 pglpl) anti-CaMKII inhibitors (Lane 3). After a 3 
minute pre-incubation with these components at 30°c, 3 2 ~ - ~ ~ ~  (10000 cprdpmol) was 
added to 25pbl final concentration and incubated for two minutes at 30O~. Reactions were 
11 1 
terminated by adding 10% SDS to a final concentration of 1% and boiling for 5 minutes. 
Densin- 1 SO was i unoprecipitated from the denatured phosphorylation reactions with 
M2 anti-densin- 180 antibody and applied to SDS/6% polyacrylamide gels. The 
autoradiograph of a 16-hour exposure of the dried gel is shown. Densin- 180 protein bands 
are indicated with an mow. 
Figure 7. Densin- 180 mRNA expression is brain-specific and densin- 180 protein is 
enriched in detergent-extracted PSD fractions. A. Densin-1 80 northern blot. Five 
micrograms of PolyA+ RNA from 13 different different tissue samples was 
electrophoresed on a 1 % agarose gel. The mRNA was transferred to Zeta-Probe blotting 
membrane (Bio-Rad) and all lanes were determined to have equal amounts of R.NA by 
methylene blue staining. Blots were probed with a random-prime labelled PCR amplified 
DNA fragment of densin- 180 spanning nucleotides 1 100-2 170 (Specific activity: 1 o9 
cpdpg).  A single broad band at 7.4 kb was detected (arrow) on autoradiographs exposed 
for 14 days with intensification screen. The blot was then stripped and re-probed with the 
2kb random-prime labelled human p-actin cDNA (from CLONTECH), (Specific activity: 
lo7 cpdpg). The autoradiograph of an eight-hour exposure with intensification screen is 
shown in the lower panel. The two forms of beta-actin are indicated (arrows). B. 
Enrichment of densin- 180 protein in detergent-extracted PSD fractions. I 
were prepared with 50pg (lanes 1 and 2) of rat brain homogenate (Hom) and synaptosome 
fractions (Syn) and 7.5pg (lanes 3-6) each of synaptosome (syn), once triton extracted 
PSD (IT), twice triton extracted PSD (2T), and once triton then sarcosyl extracted PSD. 
Densin- 180 protein band (mow) is visualized with M2 anti-densin- 180. Molecular weight 
markers and position of the dye front (open arrowhead) are shown at left. 
Figure 8. Immunocytochemical localization of densin- 180 at synapses in dissociated 
hippocampal neurons. (A-C) Dissociated E1 8 hippocampal neurons were grown in 
culture on coverslips for 14 to 21 days, and fixed with ice-cold methanol. After incubating 
coverslips 1 hour in pre-block and overnight with primary antibodies, cultures were 
washed three times with pre-block and incubated with Cy3-conjugated goat anti-mouse and 
FITC-conjugated goat anti-rabbit secondary antibodies. The coverslips were then washed 
and mounted in solution containing 80% glycerol, 4 m g / d  p-phenylenediamine and 0.1 M 
sodium bicarbonate buffer, pH9.2. Confocal images were generated using a Zeiss 
confocal microscope and double images generated in Adobe Photoshop. Red pseudocolor 
is used for the Cy3 staining and green for the FITC staining. Regions of overlap are 
yellow. A. Double staining for synapsin I and densin- 180. Anti-synapsin I (Collette 
1 : 1,000) and anti-densin- 180 (M2, 1 : 150) were used for double labelling dissociated 
cultures after 2 1 days in vitro. A 63X objective image with densin- 180 (red) and synapsin 
I (green) staining is shown. The inset at left is a 3X zoom of the area included in the white 
box. At right are the unprocessed images of densin- 180 (top) and synapsinI (bottom). B. 
Densin- 180 and PSD-95 double staining. Anti-PSD-95 (Frances, affinity pure, 1 : 100) and 
anti-densin- 180 (M2, 1 : 150) double staining of cultures grown for 17 days in vitro is 
shown. A 63X objective double-label image with a zoom factor of 1.5 is shown. Axon 
initial segment densin- 180 staining is indicated with an arrow. The upper left inset is a 2X 
zoom showing examples of colocalized PSD-95 staining (small arrows) and densin- 180 
staining (large arrows). Also indicated is a region of PSD-95 staining that does not have as 
much densin- 180 staining (small arrowhead). C. Anti-aCaMKII(6G9, 1 500) and 
anti-densin-180 (CT245, 1:3000) double staining of cultures grown for 14 days in vitro is 
113 
shown. A 63X objective image with a zoom factor of 2 is shown. The upper left inset is a 
2X zoom showing examples of colocalized aCaMKI1 staining (small arrows) and 
densin- 180 staining (large arrows). Also indicated is a region of cytoplasmic aCaMKII 
staining within the dendrite that does not have densin-180 staining (small arrowhead). 
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The expression of densin-180 and other synaptic 
markers reveals an ordered assembly of postsynaptic 
density proteins during synapse formation in culture 
INTRODUCTION 
The study of synapse formation at the neuromuscular junction has been an active 
area of study over the last 15 years, in large part due to the establishment of tissue culture 
systems. For example, in cultured chick myotubes, researchers are able to visualize axon 
ingrowth, initial contact with the myotube and synapse maturation in situ. They have also 
been able to purify factors that effect synapse formation in culture. For example, the 
addition of purified Torpedo agrin to non-innervated myotubes causes clustering of 
AChRs. Also, ARIA has been identified as a factor released by the presynaptic terminal 
that induces the expression of the adult form of the AChR. Interestingly, axons find 
previous synapses if allowed to grow back after axotomy, probably due to the organization 
of the postsynaptic specialization. The studies of synapse formation at the neuromuscular 
junction have important biological implications in the treatment of diseases such as 
myasthenia gravis or muscular dystrophy. These findings are summarized in Haydon and 
Drapeau, 1995. 
Most of what we know about synapse formation in the mammalian brain has been 
from studies of the formation of specialized brain structures such as barrel fields in rat or 
ocular dominance columns in the monkey. Groups that study synapse formation in these 
systems have used pharmacology to determine that the NMDA receptor and calcium are 
important players in synapse formation in the brain. However, the research of synapse 
formation in the central nervous system (CNS) has progressed at a much slower rate than 
than in the neuromuscular junction (NMJ), in part due to the lack of a good system to 
study the function of individual proteins. Also, the relatively small size of the CNS 
synapse makes protein localization by conventional light microscopy more difficult 
(synaptic junctions are on the order of 1 pm2 in the CNS and 500 pm2 for the NMJ 
synapse). 
Our lab and others have turned to confocal imaging of cultured dissociated 
hippocampal neurons to visualize individual synapses. This technique has been used to 
colocalize PSD-95 and NR2B at synapses (Kornau et al., 1995). I have previously 
reported the colocalization of densin-180 with the synaptic markers PSD-95, (rCaMKU 
and synapsin I (Chapter 3). Here, I describe the order of assembly of densin- 180, 
synapsin I, PSD-95, and aCaMKI1 during the synapse formation in dissociated 
hippocampal neurons in culture. 
MATERIALS AND METHODS 
Immunoblots of rat brain fractions 
Rat brain homogenates were prepared from rats anesthetized with halothane. Brains were 
rapidly dissected after decapitation and homogenized in PBS + protease inhibitors 
(Boehringer Mannheim) + DNAse 50U/ml, in a glass teflon homogenizer. Homogenates 
were flash frozen in aliquots and stored at -80aC until used for preparation of i 
probed with anti-densin- 180 (M2, 1 :3000 dilution [see Chapter 3 for description of 
antibodies]). 
Immunofluorescent staining of dissociated hippocampal neuronal cultures 
We cultured dissociated hippocampal neurons exactly as described in Chapter 3. Culture 
coverslips were fixed at 3,5,7,9, 14 or 21 days after plating (days in vitro, DIV). The 
fixed cells were then double labeled as described in Chapter 3 using the same antibodies. 
For clarification, the antibodies used were CT245 (rabbit anti-densin- 180), M2 (mouse 
polyclonal anti-densin- 1 80), 6G6 (mouse monoclonal anti-PSD-95), 6G9 (mouse 
monoclonal anti-aCaMKII), or Collette (rabbit anti-synapsin I). The antibodies were used 
at the following dilutions: CT245 serum, 1 :5000; M2 ascites, 1 : 150; 6G6 ascites, 1:500; 
6G9 ascites, 1:500; Collette, 1 : 1000. 
Controls for brightness and contrast settings in younger cultures 
The Zeiss laser scanning microscope has a very high sensitivity, so it is possible to detect 
nonspecific staining if the contrast values are set very high. This becomes a problem when 
viewing weak staining in young cultures. Thus, in each experiment we used staining of 
older cultures as a positive control for our antibodies. This enabled us to determine the 
range of contrast and brightness settings we could use and still get specific staining of 
synapses in older cultures (specificity was determined by preabsorptions, see Chapter 3 
and Appendix I). The same range of contrast and brightness values was then used to view 
the younger cultures. These controls were especially important in determining the relative 
amount of 6G9 staining in younger cultures (see results). Generally, the brightness values 
were set at 9650-9700 and the range of contrast values varied between primary antibodies. 
Contrast values used for each primary were as follows: M2 and CT245 ,400-420; 6G6, 
390-410, Collette, 350-375 and 6C9,360-380. 
RESULTS 
Expression of the densin-180 protein increases during synaptogenesis in the brain 
Densin- 180 is an adhesion molecule-like protein that is enriched in the PSD 
fraction and localized at the synapse (Chapter 3). I characterized the expression of 
densin- 180 during synapse formation in the brain by preparing immunoblots with 
homogenates from rat brains at different developmental stages. Imunoblots were 
visualized with alkaline phosphatase-conjugated secondary antibodies, a method that is not 
quantitative but can determine relative levels of protein. Densin-1 80 protein is first detected 
at P2 and increases gradually through P14 where it reaches a maximum level (Figure 
4.1A). This time course is similar to the expression of PSD-95 and aCaMKII (Figure 
4.1B) that are induced between postnatal day 8 and 18, a period of rapid synaptogenesis in 
the brain (see Cho et al., 1992). However, one notable difference is that densin-180 
reaches a maximum level of expression 4 days earlier than PSD-95 or ctCaMKII. 
Densin-180 is highly expressed before synaptogenesis, then becomes clustered 
during synaptogenesis in dissociated hippocampal neurons 
To further characterize the expression pattern of densin-1 80 during neuronal 
differentiation and synapse formation, dissociated E 18 hippocampal neurons were fixed 
for staining at various developmental stages in culture (Figure 4.2). Densin- 180 was 
expressed in golgi-like staining in the cell body and patchy staining neurites at 1 to 3 days 
in vitro (DIV). The patchy membrane-like surface staining increased through 5 days in 
vitro (DIV) when the first densin-180 clusters began to form. These clusters increased in 
number and size through 14 DIV. By 14 DIV, the majority of densin-180 staining is found 
as clusters and the patchy membrane and Golgi-like staining is diminished. The largest 
increase in numbers of cells with clusters and the number of clusters per cell occurred 
between about 7 and 10 DIV, a period of active synapse formation in culture (Bartlett and 
Banker, 1984). 
Clusters of densin-180 appear at early synapses in cultured hippocampal neurons 
double-labeled with synapsin I 
As mentioned in Chapter 3, our lab has developed a method for staining dissociated 
hippocampal neurons with antibody markers of the synapse. I decided to use 
double-labeling of densin- 180 with synapsin I, PSD-95 and aCaMKII antibodies to 
determine the order of assembly of PSD proteins during synaptogenesis. 
Dissociated hippocampal neuronal cultures were double labeled with M2 
anti-densin- 180 and Collette anti-synapsin I. Synapsin I antibodies typically stain the 
cytoplasm of axons in young cultures through 5 to 7 DIV. At around 7 DIV, synapsin I 
staining becomes associated with clusters at sites of presynaptic boutons. Figure 4.3A 
shows the typical synapsin I staining at 7 DIV (green). Interestingly, the clusters of 
densin- 180 staining colocalize with these early synapses detected with synapsin I staining. 
By 9 DIV, there is an increase in the clustered synapsin I staining and a decrease in the 
cytoplasmic axon staining (Figure 4.3B). Clusters of densin- 180 colocalize with some of 
these synapsin I clusters. Differences between the two patterns of staining are also 
indicated in Figure 4.3. Densin-180 has a high cell body staining that does not overlap 
with synapsin I staining. The axon-associated synapsin I staining and some of the clusters 
of synapsin I staining do not colocalize with densin- 180 staining. 
Clusters of densin-180 staining colocalize with PSD-95 
129 
Having established that densin-180 staining first appears in clusters at the earliest 
synapses, I tested whether the other PSD proteins gave similar patterns of staining. At 7 
DIV, PSD-95 first appears at sites of densin-1 80 clusters (Figure 4.4A). The staining of 
PSD-95 is extremely bright with very low background in the cell body or cytoplasm, 
consistent with a high degree of localization of PSD-95 protein at synaptic sites. Figure 
4.4B shows "cocl~sters'~ at 9 DIV in which clusters of densin-180 staining is colocalized 
with PSD-95 punctate staining (arrows). Some of the "coclusters" have slightly more 
PSD-95 or densin- 180 staining (mowheads in Figure 4.4B). This variation could be due 
to slight differences in the focal planes of the two lasers used in the double images. As 
development progresses between 5 and 14 DIV, there is a decrease in the patchy 
membrane staining of densin- 180 and an increase in the number of PSD-95/densin- 180 
"coclusters" per cell. By 2-3 weeks in vitro, there is almost complete colocalization of the 
two antibody staining patterns (see Chapter 3, Fig. 8B). 
Induction of aCaMKII expression is not required for densin-180 cluster formation 
Next, we viewed double-labeled images of aCaMKII and densin-1 80 at various 
stages of neuron development in culture (Figures 4.5 and 4.6). Figure 4.5A shows the 
typical pattern of very early olCaMKI1 staining at 7 DIV. The aCaMKII staining is 
associated with the cell body in large clusters that do not seem to colocalize with the 
densin- 180 cell body staining. At 9 DIV, the majority of neurons still have relatively low 
aCaMKII expression. However, there are some cells that have the very high cytoplasmic 
staining and punctate staining along the dendrites that are typical of mature neurons. The 
cells that have high aCaMKII staining always have clustered densin- 180 staining along the 
dendrites (Figure 433). On the other hand, there are a number of neurons that have 
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DISCUSSION 
Our lab has studied proteins that are concentrated in the postsynaptic density 
fraction of the brain. Here, I presented data that suggests that densin-1 80 expression in the 
brain is induced at about the same time as two other PSD proteins, aCaMKU and PSD-95. 
The expression of all three proteins is induced during a period of rapid synaptogenesis in 
the brain. 
To determine the order of expression of these synaptic markers in the individual 
neuron, I used double labeling of primary hippocampal cultures. First, I characterized the 
expression of densin- 180 during synaptogenesis in these cultures by double labeling with 
synapsin I, a marker of the presynaptic terminal. At early ages, there is an obvious lack of 
colocalization of these two markers. The densin- 180 protein is expressed in the cell body 
and along the dendrites, but synapsin I is present in the cytoplasm of axons. I could detect 
early sites of synapse formation at 5 to 9 days in vitro that have clusters of synapsin I 
staining that are likely to be associated with the development of presynaptic boutons. 
These presynaptic boutons partially overlapped with clustered densin- 180 staining. 
Next, I was able to distinguish "coclusters" of densin- 180/PSD-95 staining along 
dendrites in early synapses, but I was not able to resolve whether one clustered before the 
other. One possibility is that clusters form through interaction of PSD-95 with the PDZ 
domain of densin- 180. A PDZ-PDZ type of interaction has been postulated for the 
binding of PSD-95 with nNOS and syntrophin (reviewed in Gomperts, 1996). A direct 
interaction between densin-1 80 and PSD-95 has not been determined, but could be tested 
in vitrcl. 
There is also recent evidence for a role of PSD-95 in clustering membrane proteins 
such as NR2B and potassium channels through a PDZ-tSXV domain interaction (see 
Gomperts, 1996 for review). Interestingly, others in the lab have shown that PSD-95 and 
NR2B are "coclustered" at these early synapses. This suggests that PSD-95 may be 
responsible for clustering NR2B and/or densin- 180 at glutamatergic synapses. 
There was a notable difference in the staining of aCaMKII compared to the other 
PSD markers (densin- 180 and PSD-95). The expression of aCaMKII appears to be 
tightly regulated in the neurons and is only detected in cells that already have extensive 
synaptic labeling. A possibility is that aCaMKII-negative cells correspond to the younger, 
undifferentiated neurons in these cultures and that aCaMKII is induced during 
differentiation into mature glutamatergic neurons. 
The idea that aCaMKII is a marker of mature synapses is consistent with data from 
several other labs. First, some early experiments were carried out by Kelly and Cotman on 
isolated synaptic junction fractions (SJs) from rats of different ages (Reviewed in Cotman 
and Kelly, 1980). They noticed that the association of the "major PSD protein" with SJ 
fractions was highly regulated during development. They proposed that the major PSD 
protein is recruited to synapses at later stages of development to stabilize the PSD. This 
major PSD protein has been identified as the a subunit of CaMKII, (Kennedy et al., 1983). 
Next, studies of the aCaMKII knockout mice reveal that they are still able to form 
glutamatergic synapses. However, the mutant mice are deficient in long tern potentiation 
(LTP), a form of synaptic plasticity (Silva et al., 1992). This observation supports the idea 
that aCaMKII is not necessary for synapse formation, but might be essential for mature 
synapse function. Lastly, in a recent seminar at Caltech, Roberto Malinow presented data 
suggesting that CaMKII activity is necessary for the induction of LTP in cultured El8 
hippocampal neurons. He also suggested that the first appearance of LTP in these neurons 
is correlated with aCaMKII expression at about 9 DIV. 
Based on this information and the data presented here, I propose the following 
model for the stepwise assembly of PSD proteins the synapse. First, before synapse 
formation, densin- 180 is highly expressed all over the dendritic membrane surface and is 
available to mediate adhesion when initial contact is made between dendrite and axon. 
After contact is made, there is a coordinated differentiation of the pre and postsynaptic 
components. The differentiation of the presynaptic bouton can be detected by clustering of 
synapsin I staining. The corresponding assembly of the postsynaptic density of 
glutmatergic synapses can be detected at sites of densin- 180PSD-95/NR2B coclusters. 
Some time after these initial synapses are formed, aCaMKII expression is induced and 
recruited to the postsynaptic density. The punctate nCaMKII staining along dendrites may 
be a marker of mature excitatory synapses on glutamatergic neurons capable of exhibiting 
long term potentiation. 
In conclusion, in vitro synapse formation can be followed in dissociated 
hippocampal cultures using antibodies generated against the synaptic markers densin- 180, 
PSD-95 and aCaMKII. By following the expression of individual proteins during synapse 
formation, I have developed a model for the step-wise assembly of these proteins at the 
synapse. We could test this model by altering the levels of each protein using antisense 
oligonucleotide experiments. This could futher clarify our hypotheses about the 
involvement of densin- 180 in adhesion and initial synapse formation, the role of PSD-95 
in NMDA receptor clustering and/or densin- 180 clustering at synaptic sites, and the role of 
the aCaMKII protein in synapse maturity. The identification of the proteins involved in 
CNS synapse formation has important biological implications. This information could be 
useful in studies of synapse formation during brain development, synaptic plasticity in 
adult brain, and the pathology and treatment of brain diseases. 
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FIGURE LEGENDS 
Figure 4.1. Densin- 180 expression is induced during synaptogenesis in the brain. 
A. Brain homogenates from El  8, P2, P7, P10, P14, P18 and P50 were prepared and 25 
micrograms of each were loaded on a 7.5% SDS-polyacrylamide minigel for immunoblot 
analysis. The densin-180 protein band was visualized with the M2 antibody and an 
alkaline-phosphatase conjugated goat anti-mouse secondary antibody. B. This panel is 
adapted from Cho et al. to show the expression of PSD-95 and aCaMKII in the brain 
during development. Imunoblots were prepared with brain homogenates as described in 
Cho et al. The PSD-95 protein was detected with Frances antibody and the aCaMKII 
protein was detected with 6G9. 
Figure 4.2. Clusters of densin- 180 staining form during synaptogenesis in cultured 
hippocampal neurons. Densin- 180 staining of hippocampal neuronal cultures at 3,5,9, 
and 14 days in vitro (DIV) is shown. Cells were stained with the M2 anti-densin-180 at a 
1 : 150 dilution and a Cy3-conjugated goat anti-mouse secondary antibody. Images were 
collected using the Zeiss LSM software with contrast values 410-424 and brightness 
values were 9650-9"70. 
Figure 4.3. Densin-180 and synapsin I staining during early synapse formation in culture. 
This figure shows densin-180 staining with the M2 antibody (red) and synapsin I staining 
with the Collette antibody staining (green). Secondary antibodies were Cy3 goat 
anti-mouse and FITC goat anti-rabbit. As shown in (A), cells grown 7 days in vitro (DIV) 
show synapsin I staining in the cytoplasm of axons and in clusters at sites of densin- 180 
clusters (arrow). Arrowheads denote differences in synapsin axonal staining (top 
arrowhead) and densin-180 cell body staining (bottom arrowhead). By 9 days in vitro (B), 
more of the synapsin I staining is clustered at sites of densin-180 staining and less 
synapsin I staining is associated with axons. Arrowheads depict different cell body 
localizations of synapsin (left arrowhead) and densin- 180 (right arrowhead). 
Figure 4.4. Densin- 180 and PSD-95 staining during early synapse formation in culture. 
The densin- 180 protein is visualized with the CT245 antibody and PSD-95 protein is 
visualized with 6G6 staining. We used Cy3 goat anti-rabbit and FITC goat anti-mouse 
secondary antibodies. Densin-180 staining is red and PSD-95 staining is green. Arrows 
indicate regions of overlapping staining; arrowheads indicate where there is more 
densin- 180 staining relative to PSD-95 (left arrow) or more PSD-95 relative to densin- 180 
(right arrow). (A) PSD-95 staining is associated with clusters of densin-180 staining at 7 
days in vitro. These coclusters of double staining increase in number by 9 days after 
plating (B). 
Figure 4.5. Densin- 180 and aCaMKU staining during early synapse formation in culture. 
The densin- 180 protein is visualized with the CT245 antibody (red) and the aCaMKII 
staining is visualized with 6G9 staining (green). We used Cy3 goat anti-rabbit and FITC 
goat anti-mouse secondary antibodies. A double labeled image of cultures fixed at 7 DIV 
is shown in (A). One cell in this field shows the typical earliest detectable aCaMKII 
staining. This staining is present as large aggregates in the cell body (one such aggregate is 
shown with an arrowhead. All cells in this field stain with anti-densin- 180 in the typical 
pattern for 7 DIV cultures (arrowhead). In (B), there is a single cell with the high cell body 
aCaMKII staining usually seen in older neurons (large arrow). However, most cells show 
the staining pattern of the cell marked with an arrowhead. Small arrows indicate regions of 
densin clusters that colocalize with aCaMK11 staining. 
Figure 4.6. aCaMKII staining is absent from some neurons even after 14 days in vitro. 
Cells were stained with antibodies exactly as described in Figure 4.5. One cell in this 
image (arrowhead) has the high level of aCaMKII expression that is typical of most older 
cultured neurons (4-5 weeks in vitro). This staining is highly colocalized with densin-180 
clusters along the dendrites of this cell. However, another cell in this image stains with 
anti-densin- 180 but not with anti-aCaMKII (arrow). 
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Characterization of the specificity 
of mouse and rabbit anti-densin-180 antibodies 
In this section, I have included some controls that determined the specificity of 
rabbit (CT245) and mouse (M2) anti-densin- 180 antibodies for imunocytochemistry of 
dissociated hippocampal neuronal cultures. 
The materials and methods used for staining with the rabbit and mouse anti-densin- 
180 antibodies and the conditions used for pre-absorption are described in Chapter 3. 
Figures I. 1 and 1.2 show that the punctate clusters, the cell body staining and the patchy 
membrane staining are all removed by pre-absorption with antigen. Figure 1.3 shows that 
both anti-densin- 180 antibodies give identical staining patterns in the same neuron. 
The antibodies raised against the extracellular domain (M2) and the cytoplasmic 
domain (CT245) of densin- 180 could be used for double-labeled imuno-electron 
microscopy. These antibodies could determine whether the domains of densin- 180 are 
extracellular, presynaptic or postsynaptic. The inset in Figure 1.3 shows that we cannot 
make this determination at the resolution of the light microscope. 
FIGURE LEGENDS 
Figure I. 1. M2 staining (bottom panel, 63X, zoom=l) and pre-absorbed M2 staining (top 
panel, 63X, zoom=l) of cultured hippocampal neurons at 9 days in vitro. Pre-absorption 
removes all of the membrane and punctate staining but a slight background in the cell body 
remains. 
Figure 1.2. CT245 staining (bottom panel, 63X, zoom=1.5) and pre-absorbed CT245 
staining (top panel, 63X, zoom=l) of cultured neurons at 9 days in vitro. The membrane, 
punctate and variable cell body staining patterns are removed by pre-absorption. 
Figure 1.3. M2 and CT245 anti-densin- 180 double-labeling of cultured hippocampal 





Brain immunocy tochemistry using 
mouse and rabbit anti-densin-180 antibodies 
I used the M2 and CT245 anti-densin- 180 antibodies to stain 50 pm sections from 
fixed rat brains. For the immunocytochemistry of fixed brain tissue, rats were perfused 
with fixative (4% parafomaldehyde/0.2% glutaraldehyde10. 1 M NaP04 buffer). Next, 
brains were removed and post-fixed. At 2 hours after the initial perfusion, brains were 
placed in ice-cold PBS (20 mM NaP04, pH 7.4,0.9% NaC1). 50 micron sections were 
made using a vibrotome in an ice-cold chamber filled with PBS. Sections were 
pemeabilized with 0.7% Triton X-100 in PBS for 1 hour at room temperature, rinsed 
twice with PBS, blocked with 0.1 M glycine in PBS and rinsed twice with water. After a 
10 minute incubation, cells were rinsed twice with water and pre-blocked in pre-block 
buffer (see Chapter 3) for 2 hours. All subsequent antibody incubations and mounting 
procedures were exactly as described for cultures in Chapter 3, except that wash times were 
increased to 30 minutes each. 
At low magnifications, densin- 180 staining with the M2 antibody can be seen 
throughout the neuropil in the hippocampus, thalamus and cortex regions of the brains of 5 
and 10 week old rats (data not shown). At higher power, there is punctate staining in the 
neuropil of various brain regions that is likely to correspond to synapse staining. In 
addition, a certain type of neuron stains for densin- 180 all over the membrane surface and 
cell body. A large number of these cells are found throughout the thalamus, brainstem and 
spinal cord. In addition these "surface-staining" cells represent a small population of 
neurons scattered throughout the cortex and hippocampus. Lastly, purkinje cells in the 
cerebellum have a very high cell surface densin-1 80 staining. All of the staining described 
disappears after preabsorption of the M2 antibody with antigen (data not shown). 
Figure 11.1 shows the molecular layer of the hippocampal CA3 region from a 5 
week old rat that has been double-labeled with the M2 anti-densin- 180 and Frances anti- 
153 
PSD-95 antibodies. The primary antibodies were visualized with an FITC-conjugated goat 
anti-mouse and CY3-conjugated goat anti-rabbit secondary antibodies. The morphology of 
several "surface-staining'' densin-180 positive cells can be seen at higher magnifications 
(Figure 11.1, CA3 region and Figure 11.2, CAI region). Often, these neurons have small 
cell bodies, thin processes and do not stain with anti-PSD-95 antibodies. The densin-180 
staining of these neurons is reminiscent of the staining seen in younger neurons in culture 
that also do not yet express PSD-95 (see Chapter 4). It is possible that anti-densin- 180 
stains undifferentiated neurons in the hippocampus that have not formed glutamatergic 
synapses. This is supported by the obervation that the densin- 180-positiveRSD-95- 
negative neurons are rarely found in the cell body layers of the hippocampus that usually 
contain mature pyramidal neurons. 
In many of our double-labeled images, there are thin processes that have high 
densin- 180 staining throughout the membrane surface, but no PSD-95 staining. One 
possibility is that this staining corresponds to the dendritic filopodial extensions viewed 
developing in "real time" in hippocampal slice cultures (Dailey and Smith, 1995). There is 
also electron microscopic evidence for similar dendritic extensions in the brain (Saito et al., 
1990). 
The CT245 anti-densin- 180 antibody staining was more variable than the M2 anti- 
densin- 180 staining, possibly due to sensitivity of the epitopes to fixative or incomplete 
pemeabilization. However, I was able to detect synapse-like staining in the CAI region of 
the 10 week old rat brain (Figure 11.3). Also shown is process that extends through the 
molecular layer and contains both the high membrane surface staining and the punctate 
staining associated with synapses (Figure II.3, see left side of inset). A process that does 
not have the high membrane-associated densin- 180 staining but does contain a number of 
synapses along its length is shown for comparison (Figure 11.3, see right side of inset). I 
hope to determine fixation and permeabilization conditions that give consistent specific 
staining with the CT245 antibody. Eventually, the mouse and rabbit anti-densin antibodies 
could be used for double-labeling to localize densin- 180 at the synapse by electron 
microscopy and confirm the transmembrane orientation described in Chapter 3. 
In Chapter 4, I put forward the hypothesis that densin-180 is expressed on the 
membrane surface of young neurons in culture where it may mediate adhesion and neurite 
outgrowth. During synapse formation in these neurons, the densin-1 80 cell body and 
membrane surface staining that is typical of younger neurons becomes clustered at synaptic 
sites. Interestingly, the anti-densin- 180 staining of fixed rat brains is consistent with the 
staining we have seen in cultured neurons. Densin- 180 antibodies reveal a punctate, 
synapse-like pattern of staining in the neuropil. Additionally, a subset of neurons have 
high cell body staining and membrane staining typical of immature neurons in culture. The 
similarities between the densin-1 80 staining of dissociated hippocampal cultures and of the 
adult rat hippocampus suggests that there may be dynamic mechanisms of neurite 
outgrowth and synapse formation that persist in the adult brain. Lastly, the high densin- 
180 staining of thin filopodia-like processes in the hippocampus suggests a role for densin- 
180 in the dynamics of synapse formation. 
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FIGURIE: LEGENDS 
Figure 11. I. Densin- I80 (green) and PSD-95 (red) double labeling of the molecular layer 
in the CA3 region of the hippocampus. The cell body layer is at the upper left comer of the 
image. Cells and thin processes that stain for densin- 180 and not for PSD-95 are shown 
with arrowheads. Star-shaped structures that are often stained with the M2 anti-densin-180 
antibody are shown with smaller arrowheads. A dendrite that stains for both PSD-95 and 
densin- 180 is indicated with an arrow. Scale bar, 15 pm. 
Figure 11.2. Densin- 180 (green) and PSD-95 (red) double-labeling of the molecular layer 
in the CAI region of the hippocampus. Cells and processes that stain for densin- 180 and 
not for PSD-95 are shown with arrowheads. Scale bar, 10 pm. 
Figure 11.3. Montage of two 63X images of CT245 anti-densin-180 staining in the CAI 
region of the hippocampus. A long "surface-staining" process is shown with arrows. The 
inset compares this process (left) with another dendrite (right) that lacks "surface-staining." 






Identification of citron in the PSD fraction 
In Chapter 3, I described the cloning of densin-1 80 based on peptide sequences 
obtained from the "PSD-up180 protein band in the PSD fraction (Chapter 2). However, 
only three out of seven peptide sequences obtained from the PSD-up180 band were found 
in the densin-180 peptide sequence. I recently perfomed a BLAST search of the database 
through the National Center for Biotchnology Information using the amino acid sequences 
of the other four PSD-up180 peptides (Fig. III. 1). The BLAST search revealed that all 
four peptide sequences were identical to citron, a novel protein that binds to RhoA, RhoB, 
RhoC, and Rac 1, members of the Ras-related small GTP-binding proteins. 
Citron is a novel protein that was cloned using the yeast two-hybrid system with 
RhoC as bait (Madaule et al, 1995). Twenty clones from a mouse embryo cDNA library 
were obtained, but only one clone displayed strong reactivity with GTP-bound forms of 
RhoC and RhoA in overlay assays and was termed citron. Using polyhistidine or 
glutathione-S-transferase (GST) tagged proteins, Madaule et al. also found that citron binds 
to Rho& RhoB, RhoC and Racl in a GTP-dependent manner in vitro. 
The predicted amino acid sequence of citron contains several motifs found in signal 
transduction molecules and cytoskeletal elements. The N-terminal region of citron is made 
up of a large coiled-coil region that is distantly related to myosin and may mediate 
dimerization of citron. Next, a plekstrin-homology (PH) domain was identified in the 
citron sequence. PH domains are found in a number of proteins and are thought to mediate 
protein-protein andlor protein-membrane interactions (for reviews, see Shaw, 1996 and 
Gibson et al., 1994). PH sequences are found in a number of proteins thought to be 
involved in the regulation of small G proteins, including sos (Son of Sevenless), Ras-GAP 
(GTPase activator for Ras) and Ras-GRP (guanine nucleotide release factor for Ras) (for a 
list of other PH-containing proteins, see Shaw, 1996). Citron also contains a ring-H2 
finger, a cysteine-rich motif similar to the zinc finger domain. Interestingly, protein kinase 
C also contains PH and ring-H2 finger domains and both motifs are thought to mediate 
binding to lipid second messengers. Lastly, at the C-terminus, there is a proline-rich SH3 
binding motif and a terminal SXV (tSXV) motif (Komau et al., 1995). The association of 
citron with the PSD fraction might be mediated by the binding of citron's proline-rich 
domain to the SH3 domain of PSD-95 and/or PSD-95 binding to the citron tSXV 
sequence, 
I performed a BLAST network search using the published citron sequence to 
identify homologs. This identified some sequence similarities with three recently cloned 
Rho associated kinases: ROKa (RhoA-binding kinase, Leung et al., 1995), p160R0CK 
(Ishizaki et al., 1996) and Rho-kinase (Matsui et al, 1996). First, ROKa was cloned from 
a rat brain expression library probed with GTP-bound RhoA (Leung et al, 1995). ROKa 
is a 150 kDa protein that contains an N-terminal serine/threonine kinase domain that is 
most similar to the human myotonic dystrophy kinase. This domain is followed by a 
coiled-coil forming region and a PH domain that contains a ring-H2 domain insert in the 
loop between PH subdomains V and VI. Inserts in this position have also been identified 
in several PH domains of other proteins (Gibson et al., 1994). A comparison of the 
domain structures of ROKa and citron are shown in Figure 111.2. 
A second Rho-associated kinase has recently been cloned from mouse and termed 
1 6oRoCK. More recently, a third Rho binding kinase termed Rho-kinase was cloned 
from bovine brain (Matsui et al, 1996). Rho-kinase and ROKa are probably bovine and 
rat homologs of the same protein, as both are expressed in brain, migrate at the same 
apparent molecular weight on SDS-PAGE gels, and 96% of their amino acid sequences 
are identical. 160ROCK is probably an isoform of this family of proteins that is not 
expressed in the brain. 
The Rho binding domains in citron and ROKa were identified as the smallest 
positive cDNA clones identified in the initial cloning screens. These regions are shown in 
Figure 111.2. In both cases, the Rho binding domain is partially overlapping with the C- 
terminal portion of the coiled-coil domain and the arnino acid sequences of these domains 
were unlike any Rho binding domains previously identified in other proteins. I compared 
the sequences of citron and ROKa and found that the Rho binding domains are partially 
overlapping with 37% similarity and 21% identity over 70 arnino acids (Fig. III.3a). The 
comparatively low overall homology between citron and ROKa suggests that the 
similarities in the Rho binding domains might reflect binding to the same brain-specific 
Rho-like protein. A comparison of the Rho binding domains of ROKa and the 
homologous region of p160R0CK is shown in Figure III.3b. Despite a high degree of 
homology in this region (73% similar and 59% identical residues), three gaps were placed 
in the sequences during the alignment. One possibility is that slight differences among 
these potential Rho-binding sequences are important for specificity of binding to particular 
Rho isoforms. The tissue-specific expression patterns of these proteins suggest that 
ROKCX, Rho-kinase and citron bind to brain specific Rho-like proteins and 160RoCK 
binds to Rho proteins in other tissues. 
DISCUSSION 
The Rho and Rac families of small GTPases control a variety of actin-dependent 
cellular processes in many different organisms (Hall, 1990). Some of these processes 
include tip growth of pollen tubes (Lin et al., 1996), budding in yeast (Mischke and Chant, 
1995), and membrane ruffling in MDCK cells (Takaishi et al., 1995). Recently, transgenic 
mice were generated that expressed a constitutively active human Racl in Purkinje neurons 
that produces a dominant negative phenotype in Drosophila (Luo et al., 1996). One of the 
largest defects in these mutant mice was severe ataxia accompanied by a reduction in the 
size of spines formed in mutant Purkinje neurons. One possibility is that small GTP- 
binding proteins are important for the cytoskeletal rearrangements involved in the extension 
of spines from the dendritic shaft to meet the ason terminal. 
In conclusion, I have identified citron as a component of the PSD fraction. Citron 
may be a target for the signal transduction mediated by small GTP-binding proteins at the 
synapse. Citron also contains motifs of a new class of Rho-binding proteins that includes 
the brain ROKa and Rho-kinase, as well as their homolog that is absent from brain, 
p160RoCK. The location of the Rho-binding domain near the end of a coiled-coil region 
raises the possibility that citron is a molecular motor that is coupled to GTP hydrolysis. 
Another possibility is that Rho binding translocates citron to the membrane as has been 
shown for ROKa and Rho-kinase in heterologous expression systems (see Leung et al., 
1995 and Matsui et al., 1996). 
In conclusion, the information presented here suggests a role for citron in synaptic 
functions mediated by Ras-like small GTPases, such as the proposed morphological 
changes that underlie spine formation and synaptic plasticity. 
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FIGURE LEGENDS 
Figure 111.1. Amino acid sequences of four PSD-up180 tryptic peptides are identical to 
citron. Twice-HPLC purified tryptic peptides were sequenced from peaks 12, 18,24 and 
27 of the second HPLC runs. Ambiguities in the peptide sequences are denoted by X. 
Initial yields of the first amino acid in each sequence were as follows: peak 18, 11.43 
pmoles; peak 24, 8.07 pmoles; peak 27,22.64 pmoles. Tube contamination resulted in 
ambiguities in the first four cycles in the sequence of peak 12, and the yield of the fifth 
amino acid (Val) was 1.06 pmoles. Shown below each PSD-up 180 peptide sequence is 
the corresponding sequence in citron (amino acid numbers are shown at sides). 
Figure 111.2. Comparison of the domain structures of citron and ROKa. Coiled-coil 
forming regions (boxes with diagonal lines) and ring-H2 fingers (black boxes) are shown 
for both proteins. A complete pleckstrin homology (PH) domain is shown in citron and a 
broken PH domain is shown in ROKa (boxes with wavy lines). In citron, the SH3 binding 
motif is depicted as a white box and the terminal SXV motif is shown at the C-terminus. 
In ROKa, the serine/threonine kinase domain at the N-terminus is shown as a gray box. 
Unique sequences of each protein are shown by thin black lines. 
Figure 111.3. Sequence comparisons of Rho binding domains. A. Comparison of the 
overlapping sequences found in the RhoRac binding domain of citron and the Rho binding 
domain of ROKa. Black bars indicate the extent of the Rho binding domains mapped for 
each protein. B. The same region of ROKa is compared with Rho-kinase (Rho-K) and 
p160R0CK. ROKa and RhoK are identical except for a single amino acid in each (boxed 
168 
residue). Identical residues (black) and conservative substitutions (gray) are shown for the 
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